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Foreword
The banner of “noncommunicable diseases” (NCDs) was unfurled for 
the 2011 United Nations General Assembly meeting in New York City. It 
revealed an endemic global problem of severe chronic illnesses affecting 
the health and well-being of people around the world and undermining 
economic development. From the start, this grouping of diseases was 
intended to be inclusive, providing a convenient framing for four diseases 
with four common risk factors (the 4-by-4 rubric): cardiovascular diseases, 
cancer, diabetes, and chronic respiratory diseases, with tobacco use, excess 
alcohol use, unhealthy diet, and physical inactivity as their main causes. 
The messaging worked. Global professional societies representing these 
chronic conditions joined together and coined the term NCD with the hope 
that collective action would increase public awareness, mobilize attention 
and financing, and stem the dramatic changes in disease burden that were 
affecting virtually the entire developing world. There would be power in 
numbers, they believed. 
Proponents encountered struggles along the way as the 4-by-4 framework 
did not do justice to the range of biological, epidemiological, physical, and 
emotional experiences seeking shelter under the NCD banner. In recent 
years, the banner has been stretched in new directions as other debilitating 
diseases—such as mental and neurological conditions, rheumatic heart 
disease, and more exotic conditions strongly related to poverty—adopted the 
moniker and made common cause with the NCD movement. 
I began working on global NCDs well more than a decade ago, coming to 
the topic from a background in agricultural development and undernutrition. 
Inspired by Derek Yach, who had recently created history at the World Health 
Organization by spearheading the Framework Convention on Tobacco 
Control, I became interested in the “overnutrition” end of the spectrum. As 
a program officer at the US National Institutes of Health, I was in a position 
to encourage research and research training on obesity and related diseases 
in poor countries. Initially that meant talking with a few colleagues about 
such questions as whether obesity is a risk factor or a disease (a seemingly 
innocuous question of great importance for NIH funding). 
The world has changed in the past decade, and the global health 
community is changing as well. People who care about nutrition now care 
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about malnutrition in all its forms; people who pay for antiretrovirals for 
people living with HIV/AIDS now want to prevent those same people 
from dying of heart disease; people who care about economic development 
and jobs now focus on the productivity losses of premature illness and 
death; and people who care about poverty know that NCDs are both 
cause and consequence of poverty and must be slowed for UN Sustainable 
Development Goal 1, to end poverty in all its forms everywhere. Rolling out 
the NCD banner in 2011 effectively elevated these issues to the global stage, 
and much has been achieved in the five years since. This was the first act of 
NCDs becoming a full-fledged part of the global health agenda.
The second act is the subject of this book: how to apply our growing 
knowledge in ways that can slow the growing epidemic. The chapters in 
this book deal with the nuts and bolts of NCDs in developing countries: 
how to improve health outcomes in people living with a noncommunicable 
disease, as my colleagues Ken LaBresh and Kathy Lohr describe in the final 
chapter. It’s slow and challenging work. Part of it is getting doctors to talk to 
their patients about lifestyle (Williams and LaBresh, chapter 6), improving 
diabetes medication adherence through better health literacy (Wald et al., 
chapter 4), searching for the reasons for a surge in chronic kidney disease 
(Redmon et al., chapter 7), and finding cancer before it becomes untreatable 
and unaffordable (Subramanian et al. and Krishnan et al., chapters 1 and 2). 
My colleagues worked with local communities and their health providers 
in creative ways to find solutions for the how as well as the what of NCDs. 
This is where the answers lie. Not in the halls of the UN—although the 
next General Assembly meeting on NCDs in 2018 will further advance the 
cause and the commitments to global NCDs—but with the researchers, the 
communities, the national governments, businesses, households, and funders 
who have come to care about preventing and controlling NCDs—not just to 
save lives, but to improve them while they last. 
I am excited about the breadth of capacity at RTI International to address 
global NCDs and the deep commitment of the researchers and the institute 
itself to work with developing countries to find solutions for the growing 
threat to their well-being and economies. That is why I joined RTI this year 
as Vice President for Global NCDs, and why RTI will continue the kind of 
problem-solving described in this book. 
There is far to go before the final act can be written. Governments need to 
meet their commitments made in New York, especially for financing NCD 
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prevention and control. Health systems need to shift from an acute care disease 
control model to a chronic health management model. And different sectors 
in society need to be unified on what creates societal well-being across many 
dimensions, with good health paramount.
Rachel A. Nugent, PhD
Vice President, Global Noncommunicable Diseases, RTI International
Affiliate Associate Professor, Department of Global Health, University of Washington
Preface
This book presents the results of seven pilot projects, funded by RTI 
International under an RTI Grand Challenge, to explore applications of RTI’s 
expertise and global presence to reducing the burden from noncommunicable 
diseases (NCDs) and improving patient outcomes in low- and middle-income 
countries (LMICs). 
The projects funded were to be exploratory in nature; thus, they represent 
a variety of approaches but were confined to one or more of the four 
NCDs responsible for the greatest impact on morbidity and mortality—
cardiovascular disease, cancer, diabetes, and chronic respiratory diseases. As a 
requirement for funding, each project was required to work across disciplines 
within RTI as well as with partners from the target country. 
RTI Grand Challenges have four general characteristics:
1. They target significant problems affecting humanity at large or at least 
on the scale of a nation.
2. They transcend the boundaries of scientific disciplines and political 
interests.
3. The problems addressed are perceived to be difficult and require 
significant efforts to execute. 
4. Solutions to the problems are perceived to be achievable and have 
potential for substantial impact.
All four of these characteristics pertain to improving outcomes for NCDs in 
LMICs. 
These RTI Grand Challenge projects were competitively funded for 
18 months as pilot studies. The topics were developed in collaboration with 
in-country partners who could best leverage the combined expertise of RTI 
and local clinicians, hospitals, or clinics and other primary care settings, 
government officials, and others. The studies were intended to lay the 
groundwork for subsequent projects focused on NCD prevention, detection, 
treatment, and improved outcomes.
RTI is particularly well positioned to help improve outcomes for NCDs 
globally. This topic overlaps multiple core areas of expertise for which RTI 
is known internationally, and it represents our experience in the range of 
x  Preface
disciplines required to address NCDs. In addition, RTI’s expertise includes 
developing and assessing broad-scale interventions that have the potential to 
improve health outcomes among large groups of individuals.
Improving outcomes in NCDs in LMICs is a difficult endeavor that will 
require significant effort and collaboration. However, previous research and 
program implementation indicates that outcomes for NCDs can be improved. 
Given the tremendous impact of NCDs on morbidity, mortality, and health 
care costs worldwide, there is little doubt that efforts to improve NCD 
outcomes are a global health imperative and, indeed, essential to reduce the 
burden of NCDs on the world’s populations.
The book is intended for potential international collaborators and funders. 
We believe that a better understanding of RTI’s capabilities and collaboration 
expertise will lead to further partnerships based on RTI’s growing presence 
around the world. This initial work in NCDs in LMICs will also provide the 
rationale for additional internal investment and collaboration at RTI. In these 
ways, we can enhance our ability to respond to this enormous global problem 
of NCDs and, in so doing, further RTI’s mission of improving the human 
condition. 
Kenneth A. LaBresh, MD
Introduction
Kenneth A. LaBresh and Michael T. Halpern
Background
Clinical and Epidemiological Issues
Noncommunicable diseases (NCDs), principally cardiovascular diseases, 
diabetes, cancers, and chronic respiratory diseases, are the leading cause of 
death in the United States and worldwide. Approximately 62 percent of deaths 
worldwide (almost 36 million individuals annually) result from NCDs, with 
half of these patients (18 million) dying from cardiovascular diseases and 
8 million dying from cancer.1 In the United States, NCDs are responsible 
for 87 percent of deaths; a majority of these deaths are attributable to 
cardiovascular diseases (37 percent) and cancer (23 percent).2,3
These conditions disproportionally affect low- and middle-income 
countries (LMICs). For example, 80 percent of various heart diseases occur 
in LMICs.1The risk of mortality between the ages of 30 and 70 from these 
disorders is highest in sub-Saharan Africa, Eastern Europe, and parts of Asia.2
Morbidity and mortality from NCDs are almost certain to increase over 
the next decades; they are also likely to affect LMICs disproportionately, 
with 80 percent of NCD-attributable deaths  occurring in LMICs. Global 
NCD deaths are projected to increase by 33 percent by 2030; deaths from 
cardiovascular disease, the leading cause of death in all regions except sub-
Saharan Africa, are estimated to rise from 17.1 million (2004) to 23.4 million 
deaths (2030). Cancer deaths will increase from 7.4 million to 11.8 million 
over the same period. With more than 1.1 billion adults overweight in 2010 
(312 million of whom were obese), deaths from diabetes are expected to 
increase from 1.6 million to 2.4 million over the period 2015 to 2030. Already, 
70 percent of the diabetes burden is borne by developing countries.3
In addition to the effects on morbidity and mortality, NCDs also have 
substantial economic impact. For example, the global cost of cancer in 2008 
was estimated at $895 billion, representing 1.5 percent of the world’s gross 
domestic product (GDP).4 Rates of NCDs and associated costs will almost 
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certainly continue to increase. For instance, the direct cost of cardiovascular 
disease in the United States is expected to increase from $273 billion in 2010 to 
$818 billion in 2030.5 Over the next 20 years, NCDs worldwide are expected to 
cost more than $47 trillion, representing 5 percent of 2010 global GDP. Nearly 
one-half of this cost, $21 trillion, will affect LMICs.1
Many of the morbidity, mortality, and costs associated with NCDs can 
be avoided. At least 40 percent of cancers and 80 percent of premature 
cardiovascular disease and diabetes could be prevented through smoking 
cessation, improved diets, and adequate physical activity.6 Tobacco use alone 
accounts for 1 in 6 deaths from NCDs.1 In addition, changes to existing health 
care systems and development of new systems and strategies can improve 
treatment of NCDs and NCD risk factors. Such advances can lead to increased 
life expectancy, improve quality of life, and enhance functional status; they 
also have the potential to decrease health costs. However, to reduce exposure 
to NCD risk factors and improve diagnosis and treatment of NCDs, we 
need innovative interventions, programs, policies, and technologies on the 
individual, system, and societal levels.
Addressing Noncommunicable Diseases in Low- and Middle-Income 
Countries
In 2011, the United Nations General Assembly met to discuss a new 
international agenda for NCDs. This was only the second time the General 
Assembly had ever met to discuss a health issue (the first meeting was to 
discuss AIDS). The resolution adopted by the General Assembly at this 
meeting states that the representatives in attendance:
Acknowledge that the global burden and threat of non-communicable diseases 
constitutes one of the major challenges for development in the twenty-first 
century, which undermines social and economic development throughout the 
world and threatens the achievement of internationally agreed development 
goals.7
The resolution also states that the assembled representatives
Recognize the urgent need for greater measures at the global, regional and 
national levels to prevent and control non-communicable diseases in order 
to contribute to the full realization of the right of everyone to the highest 
attainable standard of physical and mental health.7
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Directed at improving outcomes for NCDs, the World Health Organization 
(WHO) NCD Global Action Plan specifies six objectives:8
1.  Raise the priority accorded to preventing and controlling NCDs in 
global, regional, and national agendas and to internationally agreed-
upon development goals through strengthened international cooperation 
and advocacy.
2.  Strengthen national capacity, leadership, governance, multisectoral 
action, and partnerships to accelerate country response for prevention 
and control of NCDs.
3.  Reduce modifiable risk factors for NCDs and underlying social 
determinants by creating health-promoting environments.
4.  Strengthen and orient health systems to address prevention and control 
of NCDs and the underlying social determinants through people-
centered primary health care and universal health coverage.
5.  Promote and support national capacity for high-quality research and 
development to prevent and control NCDs.
6.  Monitor trends and determinants of NCDs and evaluate progress in their 
prevention and control.
As discussed by the Lancet NCD Action Group, interventions to address 
NCDs should meet rigorous, evidence-based criteria, have a substantial effect 
on health, be cost-effective, have low implementation costs, and be politically 
and financially feasible for scale-up.6
Pilot Projects Supported by the RTI International Grand Challenge
The studies that RTI International supported through this RTI Grand 
Challenge focused on 
 • understanding conditions, attitudes, and behaviors that affect 
the detection and progression of NCDs, so as to form a basis for 
interventions
• preventing development of or exposure to risk factors related to NCDs
 identifying and treating risk factors related to NCDs
• diagnosing and treating NCDs
• implementing health care delivery changes to prevent the recurrence of 
NCDs.
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Specifically, the seven studies presented in the following chapters were all 
performed in Asia, and all collaborated to varying degrees with local partners. 
They cover a range of approaches and NCD problems. They demonstrate the 
breadth of RTI’s expertise and capabilities and illustrate how we developed 
relationships necessary to work in diverse cultures. As such, these pilot 
projects address WHO NCD Global Action Plan objectives 2, 3, and 5.
Two studies in India address the barriers to screening and treatment for oral 
cancers and for cervical cancer (Chapters 1 and 2). Patients with oral cancer 
frequently present with late-stage disease. Better screening and education 
for patients are seen as potential interventions to increase the likelihood 
of earlier detection. Tobacco regulation is also recognized as an important 
potential intervention. The project on cervical cancer screening found that 
providing patient educational handouts about the disorder and its risk factors, 
fostering encouragement from husbands to undergo screening, and enhancing 
the availability of screening were important steps for early detection and 
treatment. In both cancer-related projects, the social determinants of disease 
and risk play a central role.
The third study reports on the development of a microsimulation model 
to examine low birth weight and obesity in Indonesia (Chapter 3). This 
population forecasting model was intended to be used to project the potential 
results of various interventions to reduce stunting and low birth weight, which 
are associated with the development of obesity, and to forecast future rates 
of obesity in the general population. The results of such modeling could be 
used to inform health policy and play a role in addressing WHO NCD Global 
Action Plan objectives 2 and 5, with a view to expanding national capacity 
to reduce the underlying risk of multiple NCDs and providing a platform to 
model and predict risk factor development.
The next three studies focus on interventions to prevent and treat diabetes 
and stroke. The first of these studies (Chapter 4), carried out in India, 
evaluated the use of information technology to support health literacy and 
medication use in patients with diabetes. The study set out to examine how an 
internet-based program for producing patient handouts in the local language 
might be implemented in a primary care setting, and it attempted to document 
potential benefits of such medication information, the acceptability of such 
handouts for patients, the preferred source of these handouts (physicians, 
nurses, or pharmacists), and the knowledge of and adherence to medications 
to treat diabetes.
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The next two studies both focus on stroke, which is the leading cause of 
mortality in China and Indonesia. The study in China sought to adapt the Get 
With The Guidelines (GWTG) program developed by the American Stroke 
Association to the environment of hospitals in China (Chapter 5). GWTG-
Stroke was designed to assess and improve the acute treatment of stroke and 
the secondary prevention therapies that reduce death from subsequent stroke 
and myocardial infarction. A key element in supporting improvements in the 
quality of stroke care is acquisition of the clinical data elements that can be 
used to create evidence-based quality metrics. These measures can be used 
both to track clinical performance and support improvement of care delivery. 
The primary goal of this project was to use and integrate existing electronic 
data systems to collect data while minimizing the burden on clinicians.
In Indonesia, health workers carried out a stroke prevention intervention 
in four community health centers (puskesmas) (Chapter 6). The prevention 
program sought to prompt physicians and nurses to increase the frequency 
of patient assessment and counseling needed to reduce stroke risk factors. 
The study also measured the impact of the program on clinicians’ discussions 
with patients about their stroke risk and recommendations to modify patients’ 
risk factors. The intervention used in-depth interviews with the primary 
care physicians and nurses who conducted the intervention to learn how 
to improve the intervention and to overcome barriers to implementation 
encountered in the clinics.
The final project addresses the mystery surrounding the development 
of chronic kidney disease of unknown etiology in Sri Lanka (Chapter 7), 
which has become a major health challenge. Prior assessments of potential 
etiologies have been narrowly focused and have failed to identify fully 
explainable or defensible causes of this disorder in rural, dry areas of the 
country. Although this study also did not identify a clear, single etiology, it 
did document the likelihood that several environmental or behavioral risk 
factors play a role in the pathogenesis of this severe disorder. The team made 
several recommendations for more systematic, rigorous assessments, including 
advanced laboratory studies, for future analyses.
The conditions selected for study and various disease-specific interventions 
or programs were related to the major NCDs as defined by the Lancet NCD 
Action Group6 and the WHO Action Plan,8 with one exception. The problem 
of chronic kidney disease of unknown etiology in Sri Lanka has been an 
unsolved riddle affecting working-age men for some years (as it is in many 
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countries); those grappling with the problem sought RTI’s assistance to 
assess more effectively the role of environmental toxins. Although the full 
spectrum of causes was not established, collaboration with RTI has led to the 
development of more sophisticated analytic methods to address the problem.
Going Forward
Researchers in the United States have demonstrated the ability to transform 
the delivery of care and prevent future cardiovascular events by facilitating 
system change at multiple points in the care delivery system.9-11 Changing 
the systems of prevention and care delivery relies on the flexibility of the 
professionals delivering care, supported by expertise in system change.12 
Collaborative relationships among government leaders, policy makers, and 
health care professionals in the target LMICs are essential. 
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Barriers to Screening, Diagnosis,  
and Treatment of Oral Cancers in India
Sujha Subramanian, Sonja Hoover, and Patrick Edwards
Introduction
Oral cancer is a significant cause of death worldwide. Low- and middle-income 
countries (LMICs) bear more than two-thirds of this burden. The most recent 
statistics from the World Health Organization indicate that Southeast Asia 
accounts for one-third of new oral cancer cases and 45 percent of deaths from 
it.1 More than 100,000 oral cancers will be diagnosed annually in India alone2; 
unfortunately, 60 percent to 80 percent of these patients will present with 
advanced disease, as compared with 40 percent in high-income countries.3 In 
addition, even within India, patients with low socioeconomic status bear the 
brunt of the disease because they have a higher incidence rate.4
Oral cancer includes cancers of the mucosal lip, tongue, gum, floor of the 
mouth, palate, and mouth. The risk factors traditionally associated with oral 
cancers are tobacco use (smoking or chewing) and alcohol use. In recent years, 
however, cancers of the oropharynx have been associated with the presence of 
the human papillomavirus.5 Other risk factors may include family history and 
excessive exposure to the sun. Therefore, primary prevention is an important 
aspect of oral cancer control along with screening to detect cancers at an early 
stage when treatment is most effective.
Prior research has demonstrated that oral cancer screening using visual 
inspection by trained health workers can lower mortality and is cost-
effective. A large randomized controlled trial of almost 192,000 individuals 
showed a significant reduction in mortality among those in the intervention 
arm receiving screening (29.9 cases per 100,000) versus those in the 
control arm who received only educational messages and usual care 
(45.4 cases per 100,000).6 The follow-on cost-effectiveness analysis reported 
an incremental cost per life-year saved of US $835 overall and US $156 for 
the high-risk population of those using tobacco or alcohol (or both).7 More 
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important, the analysis revealed that three cycles of visual inspection can 
be performed for less than US $6 per person in India, suggesting that this 
approach can be implemented even in a limited resource setting, especially 
when targeted at high-risk individuals. These two studies published by the 
research team serve as the key body of evidence for oral cancer screening in 
LMICs.
This chapter assesses barriers along the cancer care continuum to identify 
interventions that can be implemented to improve patient outcomes. In 
the oral cancer screening trial in the Trivandrum region, 5,145 individuals 
screened positive, but only 3,218 (63 percent) complied with follow-up 
diagnostic recommendations.6 Discussions with regional cancer center staff 
in India revealed that only about one-half of the oral cancer patients complete 
treatment. Low compliance with oral cancer care recommendations is a 
significant issue that needs to be addressed to improve outcomes. Therefore, 




For the analyses, we obtained both quantitative and qualitative information 
to identify the most promising interventions to decrease the burden from 
oral cancers. Figure 1.1 describes the framework we used to guide the data 
Figure 1.1  RTI conceptual model to assess barriers to cancer care
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collection and analysis. Patient characteristics and health system factors 
(e.g., insurance coverage is increasing in India) can affect access to care and 
quality-of-care processes. Decreased access to care includes structural barriers 
(e.g., access to providers), financial considerations (e.g., ability to pay for 
travel to seek care), and cognitive factors (e.g., understanding of treatment 
recommendations). Quality-of-care process measures include a variety of 
factors, such as coordination of care and interaction with providers. We also 
included health outcomes as measures of the quality of care, presented here in 
the cancer care continuum.
Research Partners
We partnered with two cancer centers in India: the Regional Cancer Center 
in Trivandrum City and the Kidwai Memorial Institute of Oncology in 
Bangalore (see Figure 1.2). The cancer centers offer care free to the poor and 
at a reasonable charge to those at higher income levels. Both centers provide 
oral cancer care in a specialty clinic to more than 1,000 oral cancer patients 
annually. The International Agency for Research on Cancer ran a decade-
long screening trial for oral cancers in Trivandrum district. Therefore, we 









Figure 1.2  Intervention and control clusters in the oral cancer clinical 
trial in Trivandrum City (Regional Cancer Center) and Bangalore (Kidwai 
Memorial Institute of Oncology)
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oral cancer risk factors and better informed about cancer screening than the 
patients in the Bangalore area.
Data Collection
We collected data from several different sources. One source was a patient 
survey; Figure 1.1 outlines the conceptual model of the survey. The survey 
instrument included questions in the following domains: patient demographics 
and behaviors; knowledge and attitude regarding oral cancer risk factors and 
treatment; access to care; health-seeking behavior; treatment and survivorship; 
and barriers. We pretested the survey with five representative patients at each 
site and then administered it via face-to-face interviews with patients recently 
diagnosed with oral cancer. The staff from the two cancer centers interviewed 
200 patients each (for a total of 400 patients) using a consistent protocol.
The remaining source of data consisted of two focus groups with 12 nurses 
and social workers from the Kidwai Memorial Institute of Oncology in 
Bangalore. The first group consisted of seven experienced nurses who generally 
each had more than 10 years of work experience and an average of about 
3 years working directly with oral cancer patients. The second group included 
five social workers who each had an average of 25 years of experience in cancer 
care. We used open-ended interview questions to understand interviewee 
perception of patient barriers and explore approaches to reduce the identified 
barriers.
Results
Findings from the Patient Survey
A total of 400 patients, 200 from each study site, completed the survey. The 
main findings are as follows:
• Patients with higher education are more likely to report accurately the 
risk factors for oral cancer and more likely to know about oral cancer 
screening.
• Patients receiving care at the Regional Cancer Center in Trivandrum City, 
who were likely exposed to the education messages form the decade-long 
clinical trial, consistently reported higher levels of knowledge about oral 
cancer than those receiving treatment at Kidwai Memorial Institute of 
Oncology.
• Even in the highest educated group, only two-thirds of the patients were 
correctly informed about oral cancer risk factors and screening.
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Respondents reported considerable financial barriers related to treatment, 
transportation, and the need to stay near the hospital to undergo treatment. 
The detailed findings from the patient survey are reported elsewhere.8
Findings from the Focus Groups
The barriers identified in the focus groups 
fell into two categories: (1) patient barriers 
and (2) institution or health system 
barriers. Table 1.1 summarizes these 
barriers and suggested interventions; we 
discuss the points in more detail in the 
sections that follow.
Patient Barriers
Financial Barriers. The population that 
Kidwai Memorial Institute of Oncology 
treats is very poor, with low levels of 
education. The patients tend to be day 
workers or farmers, with unstable and 
variable incomes. The interviewees 
estimated that patients earn less than 
1,000 Indian rupees per month, which is 
approximately US $16. Given the extreme 
poverty of the patients, being diagnosed with cancer creates a great burden.
Patients can choose the type of hospital where they will be treated; however, 
according to interviewees, private hospitals are more expensive than the 
regional cancer centers. Government programs are in place to assist patients 
financially, but costs associated with treatment remain. These include costs 
of surgery, postoperative care, and medications. In some cases, patients need 
to go through multiple surgeries. According to one nurse, “As long as [the 
patients] are in the hospital, they take medicines … but when they go back to 
their villages, they may not want to spend the money to buy the medicines, or 
those medicines may not be available in their village.”
Additional costs arise for travel and lodging—for family members as well 
as for patients. Patients must take time from work for treatment and may risk 
losing their jobs if they are away too long for treatment or for repeated hospital 
stays. Finances become even more difficult when the patient is the primary 
earner for the family. One social worker commented that “patients often sell 




• Lack of education
• Stigma and fear
System Barriers
• Shortage of facilities
• Shortage of staff
• Patients’ use of traditional healers 
and Ayurvedic hospitals
Suggested Interventions
• Price increase on tobacco products 
and taxes
• Education of population, health 
workers, and traditional healers
• Improvements in existing facilities
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their land and jewelry in order to meet treatment costs.” Because of the lack of 
finances, patients may forgo follow-up care and treatment, which can result in 
recurrence of the cancer. The interviewees indicated that with financial help, 
patients are more likely to follow up with postoperative care.
Education. As we noted previously, patients residing in the Kidwai area have 
very low levels of education and literacy. Because of this, teaching patients 
about the importance of prevention, screening, and treatment is difficult. 
Patients may not understand why prevention is important (e.g., why they 
should quit using tobacco products) and may not recognize the symptoms 
of oral cancer when they appear. Teaching them about postoperative care 
may also be difficult. According to one social worker interviewed, “Patients 
face most problems postoperatively, as many have lost a part of their mouth, 
like [the] tongue, and are not able to talk or eat….” Patients also must learn 
to become diligent in taking any prescription medications as adherence is 
often low.
Another issue that follows from low education levels is that patients may 
not give much priority to their own health care. Persons tend to present 
with oral cancer at a later stage of the disease because they defer screening 
(or visiting a doctor generally) for work, caretaking of others, and familial 
obligations.
Stigma and Fear. The interviewees noted the great amount of stigma and 
fear among the patients, particularly among those who reside in rural areas. 
Surgery for oral cancer can lead to disfigurement, because of losing part of the 
mouth or tongue, which can further lead to the inability to talk or eat. Some 
consequences of improper postoperative care can arise, such as foul mouth 
odor and even the development of maggots in the mouth. These sequelae can 
all lead to social isolation for the patient.
Interviewees reported that patients experience a range of emotions, 
including depression and anxiety, because of the cancer. Lack of support from 
family and friends can compound these problems. Patients fear rejection and 
need assistance after the surgery. The interviewees have seen unsupportive 
family members who do not know how to change dressings and who do not 
bring patients back for follow-up treatment. 
“Most of the oral cancer patients are elderly,” according to one social 
worker, “and may not have any family support during their illness even though 
they face several problems like not being able to eat or swallow.”
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Further, community beliefs can ostracize the patient. Some believe that 
cancer is caused by past sins, it is a curse, or it is communicable or contagious. 
Some interviewees said that these were all reasons for patients to forgo early 
detection in the event that they do have cancer. However, some interviewees 
indicated that outreach and education has helped to reduce stigma.
Institutional and Health System Barriers
Shortages of Facilities and Staff. In India, the government partially funds 
27 regional cancer centers. Kidwai is one of them, and it serves approximately 
1,000 patients annually in its oral cancer clinic. However, the oral cancer 
clinic at the hospital has only three staff physicians to support the oral cancer 
caseload: a professor, an associate professor, and an assistant professor. 
According to the interviewees, the staff physicians perform between four 
and five surgeries per day, some major and some minor. In addition, these 
physicians perform additional, nonmedical roles including administrative 
functions and counseling; these duties all take time away from their medical 
roles. Patients often have to wait several hours to receive care because of the 
limited number of staff.
The 12 interviewees indicated the need for more staff, particularly 
counselors and social workers. Patients require support both before and after 
their surgeries, but many do not receive it from physicians, nurses, or family 
and friends. Physicians, because of large caseloads, do not have the time to 
spend with patients. One nurse commented that “the doctors don’t … spend 
sufficient time with [patients] since Kidwai is a government hospital and is 
overcrowded.” Although nurses try to provide counseling, many do not have 
the time or the background to do so. In addition, although social workers 
provide counseling, many physicians do not refer patients to them because 
they believe that the social workers do not have the proper educational 
background for it. Moreover, although the social workers do attempt to help, 
their time is divided among different tasks, including providing information 
on financial assistance.
Nurses also discussed poor morale. In addition to being overworked and 
doing nonmedical tasks, the nurses feel underappreciated, because they do not 
receive the same level of acknowledgment of their contributions as physicians. 
The nurses indicated that they “don’t mind doing the work and helping 
patients, but their work should be appreciated and they should be given timely 
incentives and promotions.”
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Use of Traditional Healers. The interviewees also indicated that patients are 
influenced by the advertisements of traditional healers that promise to cure 
their conditions. These include homeopathic clinicians and other types of 
healers. Patients may opt for these modalities because the practitioners are 
local and the waiting times are shorter.
However, many of these practitioners have not been formally trained in 
how to screen and treat cancer. By the time patients who have not been cured 
present at Kidwai, their cancer is at a later stage and more difficult to treat. 
Often, the cancer is at a terminal stage, and only palliative care can be offered.
Suggested Interventions
The nurses and social workers had several broad suggestions to facilitate 
cancer prevention and treatment. They recommended that the government 
either ban tobacco products outright or increase the tax rate on or the price of 
tobacco products to discourage purchase and use. They pointed to the banning 
of gutka, a tobacco product, as an example of government involvement.
They also believed that broad-based oral cancer education and awareness 
campaigns are needed. This is particularly important because they are 
observing higher rates of smoking across all age groups, especially among 
younger and educated people. Interviewees thought that such campaigns 
could be done through mass media and cancer detection camps. Cancer 
detection camp teams conduct small-group educational sessions in hospitals 
and communities across the state. The workers are considered well versed in 
approaching and educating the community. Some cancer detection camps are 
mobile units that are equipped to screen and refer patients for treatment.
Interviewees further recommended education of health providers, 
particularly in rural areas, including traditional healers. Often, patients are not 
referred to cancer centers quickly enough because the cancer is not identified; 
even if cancer is identified, patients are treated with alternative therapies 
(e.g., homeopathy or Ayurveda). If patients present at a treatment center, 
the cancer is at a later stage, and so curative treatments cannot be provided. 
Providers and healers need to be educated about the importance of referring 
patients to cancer centers immediately upon diagnosis so that patients can 
begin treatment.
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Discussion
The findings from the patient survey and focus groups indicated numerous 
barriers along the continuum of cancer care. Better knowledge of cancer risk 
factors might motivate individuals to change their behaviors concerning use of 
tobacco and alcohol. In addition, information on the symptoms of oral cancer 
and easier availability of screening may motivate more individuals to seek 
care earlier. Education of providers, including physicians, nurses, and social 
workers, is an important component of any education campaign. Interventions 
to improve patient and provider knowledge can help shift the diagnosis to an 
earlier stage. Integrated delivery of education and screening with other cancers 
and noncommunicable diseases could provide an efficient approach to address 
multiple diseases with shared risk factors.
Patients diagnosed with oral cancer face many barriers, even though 
low-cost or free treatment is available. The regional cancer centers may be 
overwhelmed by the numbers of cases that need to be treated; which can lead 
to long wait times and limited face time with the medical staff. Resources 
allocated to the regional cancer center should be thoroughly assessed to ensure 
that staffing levels and funding are adequate for the volume of patients treated. 
Patients, especially in rural areas, may face significant expenses traveling 
and staying near the cancer center to receive care. In addition, they may 
Key Findings and Lessons Learned
• Systematically assessing facilitators and barriers from the patient perspective is 
important.
• Support medical staff, including nurses and social workers, often receive information 
directly from the patient and, therefore, can provide valuable feedback to improve 
patient experience.
• Even when cancer treatment is subsidized or free, patients face substantial 
economic burden related to travel to regional centers to receive care.
• Specialty care is available only in tertiary care centers, which can result in 
substantial economic barriers related to travel time and cost. Serious consideration 
should be given to ensuring that at least certain levels of treatment related to 
noncommunicable diseases are available in more geographically dispersed settings.
• The lessons learned in this study on oral cancer care generally apply to other 
noncommunicable diseases in low- and middle-income countries. Greater emphasis 
on early detection and more patient-friendly treatment services can make 
tremendous inroads in reducing the noncommunicable disease burden.
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not have the financial means to follow through with post-treatment 
recommendations. Approaches to minimize the financial burden may increase 
treatment compliance.
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Addressing the Challenge of Cervical Cancer 
Screening: Foundational Work in Karnataka, India
Suneeta Krishnan, Mahima Ashok, Laura Nyblade,  
Deborah Porterfield, and Melissa Stockton
Introduction
Burden of Cervical Cancer
Cervical cancer is a leading cause of cancer-related morbidity and mortality 
among women in India. In 2012, more than 120,000 women were diagnosed 
with cervical cancer in India, corresponding to an age-standardized incidence 
rate of 22 per 100,000.1 According to the World Health Organization (WHO), 
the annual burden of new cases in India will increase to nearly 225,000 by 2025 
at current incidence rates and in the absence of systematic prevention efforts.2
The considerable burden of cervical cancer in India persists despite the fact 
that effective primary and secondary prevention tools, namely vaccination 
against human papilloma viruses and screening and treatment, exist. In fact, 
WHO considers screening and treatment of precancerous lesions to prevent 
cervical cancer to be a “best buy” intervention.3 Numerous studies across India 
have demonstrated the feasibility and acceptability of cervical cancer screening 
and its effectiveness in reducing morbidity, promoting early detection, and 
preventing premature mortality.4-6 However, few large-scale organized 
screening programs have been established, and most women continue to be 
diagnosed at advanced stages with poor prognosis.7
Research and programmatic experiences in India have highlighted 
implementation-related challenges that need to be addressed for effective 
large-scale cervical cancer prevention.8 For example, recruiting large 
numbers of women to participate in screening and ensuring follow-up of 
women who require additional monitoring, testing, or treatment have both 
been difficult. In fact, a review of cervical cancer screening programs in 
low- and middle-income countries (LMICs) found India to have the lowest 
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rate of participation.9 Randomized controlled trials that used comprehensive 
mobilization efforts have been successful in meeting recruitment targets; 
these strategies include health education, personal invitations by providers 
and community members, clinics in close proximity to women, and treatment 
offered during the same session as screening.10 However, this broad approach 
has not been consistently successful in achieving high screening uptake5 or 
adherence to follow-up recommendations.11 Thus, we need a comprehensive 
understanding of the factors that help or hinder the uptake of cervical cancer 
screening and follow-up services.
Study Objectives
Our foundational study addressed this need in two ways: (1) a review of the 
literature on cervical cancer screening and follow-up experiences in LMICs 
and (2) a qualitative study in two rural districts in the southern Indian state 
of Karnataka. We had three main objectives. First, guided by the social-
ecological theory of behavior, we aimed to examine the evidence on factors 
that facilitated or posed barriers to cervical cancer screening and follow-
up across LMICs and to conduct additional research to examine factors 
specifically relevant in the Indian context. Second, using our literature review 
and formative study in India, we intended to propose a social-ecological model 
to depict how multilevel contextual factors influenced women’s participation in 
screening and follow-up. Finally, we planned to use this conceptual model to 
guide identification of interventions to improve cervical cancer screening and 
follow-up implementation in India.
Methods
Project Team and Setting
Our project drew on RTI’s multidisciplinary expertise and research 
partnerships and infrastructure in India. A transnational team with training 
and experience in social and behavioral science research, medicine, and health 
promotion conducted the study. The team included US- and India-based RTI 
staff, consultants who were part of RTI’s collaborative research program in 
India, and three undergraduate research interns (one of whom later joined the 
RTI staff).
RTI partnered with Cancer Care India, a nongovernmental organization 
focused on cervical cancer prevention in Karnataka, to conduct the qualitative 
data collection. The principal investigator of the study was based in Karnataka; 
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at the time we did this pilot study, she was also providing technical assistance 
to the state government to design, implement, and evaluate a cervical cancer 
screening and treatment initiative. Insights from this project helped shape the 
study objectives and methods.
We carried out the qualitative study in two predominantly rural districts 
of Karnataka: Bangalore Rural (population of 990,923 in 2011) and 
Chikkaballapura (population of 1,255,104 in 2011) at a distance of 50 to 
150 kilometers from Bengaluru, the capital city. Data from the Population 
Based Cancer Registries indicated that, between 1990 and 2011, the age-
adjusted rate of cervical cancer in urban Bengaluru was 18.9 per 100,000.12 
From 2007 to 2011, cervical cancer comprised nearly 28 percent of all 
cancers among women recorded by the Hospital Based Cancer Registry 
in Bengaluru, and it was the most common cancer in women.13 Although 
breast cancer has overtaken cervical cancer as the leading cancer among 
women in the Bengaluru Hospital Based Cancer Registry in the post-2011 
period, morbidity and mortality caused by cervical cancer remain substantial 
(Dr. Chaluvarayaswamy Ramesh, Kidwai Memorial Institute of Oncology, 
Bengaluru, Karnataka, India, personal communication, November 2014).
Our partner, Cancer Care India, has been promoting cervical cancer 
prevention in rural and urban communities, including in Bangalore Rural and 
Chikkaballapura districts, in Karnataka. Their prevention program includes 
education of screening-eligible women (ages 30 to 60 years) by community 
leaders and health workers about the benefits of a comprehensive health 
examination; these activities are followed by Pap smear–based screening 
through camps run by a social worker and a physician employed by the 
organization. Women who screen positive are informed about their result with 
the help of local community health workers, and they are offered facilitated 
referrals to diagnostic and treatment services provided by governmental or 
private clinics and hospitals.
Theoretical Framework
The socio-ecological theory of behavior guided our project.14-16 This 
theory proposes a range of factors operating at the levels of the individual, 
family, community, and health care system that shape an individual’s health 
behaviors. When applied to cervical cancer screening and follow-up, this 
theory encourages an examination of how individual knowledge and beliefs, 
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family relationships, community norms and perceptions, and health care 
organizational characteristics influence all these processes.
Literature Review
Building on a review of cervical cancer screening research and programmatic 
experiences in India,17 we developed a protocol to review evidence on factors 
that influenced screening uptake and follow-up across LMICs. Our review of 
the Indian literature revealed that most studies on this issue lacked theoretical 
grounding and focused on a narrow set of potential facilitators and barriers. 
Thus, we decided to conduct a more comprehensive narrative review and also 
to examine how the social-ecological theory of behavior would promote an 
understanding of the range of potential factors that may influence the success 
of cervical cancer screening efforts.
We used the following standard five-step process to implement our review: 
1. Develop key questions for the review and study inclusion and exclusion 
criteria.
2. Identify search terms and conduct an electronic literature search using 
major databases such as Medline, ISI Web of Science, and the Alliance 
for Cervical Cancer Prevention (ACCP).
3. Review titles and abstracts produced in the searches against inclusion/
exclusion criteria.
4. Retrieve full-text articles for “included” citations.
5. Review and abstract key data from all retained articles using an 
abstraction form.
The four key questions (KQs) for our review focused on the facilitators and 
barriers to cervical cancer screening (KQs 1 and 2) and post-screening follow-
up (KQs 3 and 4). We focused on the four levels of actors (i.e., individual, 
family, community, and health care system).
We included studies that were English language, peer reviewed, and 
published or in publication between January 1, 2003, and May 31, 2013. 
Included studies were limited to women eligible for cervical cancer screening 
based on age and presence of a cervix; they had to have been conducted 
in LMICs in Asia, Latin America, and Africa according to the World Bank 
definition and categorization.18 Studies were eligible if they examined cervical 
cancer screening behavior and knowledge, attitudes, or beliefs. We included 
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a broad range of study designs because the goal was to identify the breadth 
of factors related to screening uptake and follow-up that had been examined. 
We did not limit or select studies based on the rigor of their design or study 
methods.
We defined search terms through an iterative process. We identified a total 
of 191 articles and revised the abstracts for inclusion. Of these, 38 articles, 
reporting on 29 unique studies, met our inclusion criteria and were retained 
for abstraction. We ascertained the following information from selected 
articles: study design and methods, country, population, outcomes, and 
facilitators of or barriers to cervical cancer screening and follow-up. We then 
synthesized these data within the context of our theoretical framework.
Qualitative Study
Study Population
We conducted the qualitative study in two rural districts: Bangalore Rural 
and Chikkaballapura in Karnataka State. Our partner, Cancer Care India, 
purposively selected the villages to include both those that had been exposed 
to its cancer prevention education and screening efforts and those that had not 
yet been exposed.
The Institutional Review Board at RTI International reviewed and approved 
our protocols and instruments. We obtained written informed consent from all 
study participants.
Data were gathered from a range of stakeholders in the community. These 
included women who were in the screening-eligible age group of 30 to 60 
years, husbands of women in this age group, community health workers 
(e.g., physicians employed at local primary health centers, frontline health 
promoters called ASHAs [accredited social health activists], day care workers) 
and community leaders (e.g., members of the village government, women’s 
self-help group members).
Data Collection: Focus Groups and Interviews
We conducted three main data collection efforts: (1) focus group discussions 
with women and men (husbands) in the community; (2) individual or small 
group (two or three individuals) interviews with community leaders and 
health workers; and (3) individual interviews with women who had undergone 
cervical cancer screening. To steer the discussions and interviews, we 
developed a semi-structured guide based on our conceptual framework and 
the literature review, keeping in mind the challenges of translating questions 
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into the local language, Kannada. For example, given that we anticipated 
very low levels of awareness about cervical cancer and screening, we needed 
to use extremely simple terms to explore the study populations’ perspectives 
on screening through a gynecological examination. Because communities 
are aware of “uterus examinations” in the context of pregnancy, we used this 
terminology to explore factors that would influence women’s willingness to 
undergo screening. We developed discussion guides in English and translated 
them into Kannada. The India- and US-based investigators reviewed drafts and 
refined them iteratively.
Participants from villages where Cancer Care India had conducted cervical 
cancer screening programs were asked questions in several domains. These 
domains included understanding and perceptions of cervical cancer and 
screening; ways in which they received messages about cervical cancer and 
screening; and factors that influenced their decision to undergo screening. 
Interviews focused on ascertaining the factors that supported women in 
obtaining screening and what their screening experiences had been. We 
also interviewed participants from villages where cervical cancer screening 
programs had not been conducted. In those villages, we explored participants’ 
willingness and motivations to participate in screening; the type of information 
they desired; how information could be disseminated in the community; and 
where and how screening services should be offered.
Because of differences in the views and experiences of women in different 
age groups, in particular differences in power dynamics that may be age-
related, we conducted focus group discussions with women grouped by age 
(30–45 years and 46–60 years).
The research team provided information about the study to recruited 
individuals using a written informed consent form. Those who were willing 
to participate provided written consent. Interviews and group discussions 
took place in the village—at schools, health centers, or day care centers. A 
team experienced in conducting qualitative research on women’s health 
issues, including a clinician, carried out the interviews. We also collected 
sociodemographic data from participants. We recorded the discussions and 
interviews, and a professional translator translated and transcribed them. A 
member of the research team reviewed the translated transcripts for accuracy.
Analyses
We conducted a thematic analysis of the qualitative data. This involved 
reading the transcripts several times to become familiar with the content. We 
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developed a list of codes based on key themes (such as cancer awareness, fear 
of cancer, importance of quality of care). We used Atlas.ti software for coding 
and analysis.19 Two members of the team coded the transcripts.
We then analyzed the coded data to summarize key themes and to explore 
data by the levels of the socio-ecological model. We also examined different 
stakeholders’ perspectives on each theme to identify key factors that appeared 
to influence cervical cancer screening and follow-up.
Results
The appendix table at the end of this chapter describes the 29 unique studies 
(38 articles) from our review of this literature. Findings from these studies 
are incorporated in our discussion. In addition, a total of 147 individuals 
participated in our qualitative study: 81 women in the screening-eligible age 
group, 39 husbands, 11 community leaders, 10 health care workers, and 6 
women who had undergone cervical cancer screening. In this section, we 
summarize our findings organized by the social-ecological framework.
Individual-Level Facilitators and Barriers
Several individual-level factors emerged as important in the literature review 
and our qualitative study. Across LMICs, studies consistently found that 
knowledge about cervical cancer screening was an important determinant of 
screening uptake and follow-up. Knowledge about the benefits of screening 
and the treatability of cervical cancer when detected early appeared to be 
key. Women’s perception of susceptibility, a family history of cervical cancer, 
and perceived severity of the disease and its impact on reproductive health 
(particularly, fertility) and sexual duties were associated with screening 
intentions or behaviors. Similarly, our qualitative study found that women’s 
awareness of cervical cancer, understanding of the benefits of screening, and 
knowledge of someone affected by the disease—coupled with a recognition of 
the value of staying healthy—motivated them to undergo screening.
Not surprisingly, the literature review found that lack of knowledge, 
misconceptions about cancer, and fear of the disease and of treatment were 
important barriers to screening and follow-up. For example, one study found 
that fear of being diagnosed as having cancer was associated with not being 
screened; in another, concern that screening would lead to worry was a 
barrier. Our qualitative study yielded similar findings. For instance, shyness 
was identified as a barrier to screening; however, being embarrassed and 
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therefore reluctant to be examined could be overcome by greater knowledge 
of the benefits of screening. A fatalistic attitude about illness—the notion that 
contracting a disease is a predetermined part of one’s fate and must be faced as 
such—was also a hindrance to follow-up.
Household- and Community-Level Facilitators and Barriers
Studies found that husbands’ support for reproductive health or cervical 
cancer screening was important. Several studies also suggested the importance 
of support of friends who had undergone or recommended screening and of 
being able to attend screening with friends. Our field research also highlighted 
the benefits of engaging husbands to promote screening among women: in 
villages where Cancer Care India had conducted education and screening 
programs, both men and women were in favor of screening. Men talked 
about actively encouraging their wives. We also found that women who had 
undergone screening were promoting screening uptake enthusiastically to 
other women in their community.
Several studies included in the literature review reported that lack of 
family and social support was an important barrier. This was especially true 
for husbands’ support. Husbands’ lack of support could be attributed to 
discomfort with male health care providers or misconceptions about screening 
or treatment. Participants in our qualitative study noted that husbands were 
more comfortable when female health care providers were offering the service.
Health System–Level Facilitators and Barriers
Both the literature and our qualitative study identified health system 
characteristics as important factors. The screening setting was particularly 
relevant—whether the setting was accessible, was affordable, and offered 
privacy and confidentiality. In addition, studies reported that women preferred 
female health care providers. These results were echoed in our qualitative 
study. A few studies noted that community educators encouraged women to 
go to mobile screenings and that community advocacy teams could increase 
women’s participation. Women’s groups, churches, and HIV voluntary 
counseling and testing centers were also used to promote services, as were 
television, radio, and street plays. From our qualitative analysis, we found that 
recommendations of screening by women who had used the service was the 
most important form of advocacy at the community level.
Inaccessibility and unaffordability of services were frequently mentioned 
barriers in the literature. Logistical factors such as long waiting times, needing 
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to travel long distances, and infrequent availability of services were clear 
barriers to follow-up and treatment. A few studies also reported barriers to 
treating including needing to make multiple clinic visits and not having access 
to high-quality providers (preferably female).
A few studies noted negative staff attitudes and behaviors and inadequate 
messaging about the importance of screening. In our qualitative project, 
participants repeatedly emphasized health systems barriers. In particular, they 
cited rudeness of health care providers, poor organization of services, lack of 
confidentiality, cost of services, and inaccessibility for working women.
Finally, participants in our qualitative study also highlighted fear of 
community gossip and a culture of silence around women’s gynecological 
health as barriers to women coming forward to be screened.
Discussion
Key Findings
We identified a wide range of factors influencing cervical cancer screening 
and follow-up that can be organized using the social-ecological model to 
understand facilitators and barriers. Each of the levels of this model—the 
individual, family, community, and health care system—appeared to have 
a strong influence on these activities. The studies we reviewed and our 
qualitative research did not explore the relative influence of factors operating 
at these levels. In fact, the social-ecological model suggests that these levels 
are interdependent and have mutually reinforcing influences on individual 
behaviors and health outcomes.
Promoting cervical cancer prevention through screening, early detection, 
and treatment of precancerous and cancerous lesions is an important priority 
in India, which bears nearly 25 percent of the global burden of cervical 
cancer. Our research suggests that, in India and other LMICs, screening 
initiatives should pay attention to multilevel contextual factors in design and 
implementation. Indeed, our data suggest that screening programs should 
encompass a range of strategies that address multilevel influencers of service 
uptake. Interventions that simultaneously address factors operating at multiple 
levels are likely to have greater impact than strategies focused on any single 
level.
Our findings point especially to the importance of behavior and social 
change communication about cervical cancer screening and follow-up. 
Communication efforts should address individuals, families, communities, and 
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the health care system. Women and their families, especially husbands, should 
be knowledgeable about cervical cancer; they need to grasp who is at risk, what 
screening entails, and what the benefits are of screening, early detection, and 
treatment. Community leaders and health workers should be made similarly 
aware and recruited to promote screening. Health care providers, too, need to 
be educated and sensitized about women’s needs, and care should be provided 
in a respectful, private, and confidential manner. In summary, communication 
efforts should take a “whole-of-family, whole-of-community” approach.20
Community-level strategies should address the culture of silence that 
surrounds women’s health and reduce the fear associated with cancer. This 
may be accomplished through programs that offer greater visibility to cancer 
survivors. Given that women (including health workers) in our qualitative 
study who underwent screening appeared then to be active promoters of the 
service, programs might consider initially offering screening to community 
leaders and health workers. Such an approach, which a pilot project led by 
the National Institute of Cancer Prevention Research is now following, may 
not only mobilize them to promote screening but also increase women’s and 
families’ confidence in the program.
At the health care system level, programs may need to address several 
factors. Our data underscore the critical importance of ensuring that female 
health care providers are available to conduct screening. The state of Tamil 
Nadu in India is already pursuing this approach; the program deploys female 
nurses to conduct screening at the primary health care level. Screening services 
should be well organized. For example, the registration process should be 
transparent, and waiting times should be minimal. Services should be free or 
at low cost, especially for poor women. Access to health insurance, particularly 
for diagnostic testing and treatment, can promote follow-up. Finally, screening 
should be in an accessible and convenient location—either in the village or at 
a primary health center. As participants in our qualitative study emphasized, 
services should be women-centered (responding to their concerns and needs) 
and of high quality.
Implications for Programs and Research
Given the substantial burden of cervical cancer in India, scaling up 
comprehensive prevention efforts across the country is imperative. As WHO 
recommends, a comprehensive prevention effort would involve offering human 
papillomavirus (HPV) vaccination to girls aged 9 to 13 years and screening 
and follow-up services to women aged 30 to 49 years.21 As our research 
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suggests, screening initiatives in India should focus on using evidence-based 
strategic communication about behavior and social change to promote 
prevention, engaging families and communities, and ensuring that health care 
organization and delivery are responsive to women’s needs.
At the same time, we recommend conducting research simultaneously 
focused on understanding the acceptability and effectiveness of strategies 
that emphasize communication and on clarifying health care organization 
and delivery. Well-designed, rigorous investigations of the implementation 
of cervical cancer screening programs, including process and outcome 
evaluations, will further expand the evidence base for what works in LMIC 
contexts. Development of validated scales to measure cervical cancer-related 
knowledge, fear, and stigma is critical to assessing program outcomes and 
impact. More broadly, future research should draw on the implementation 
science research toolkit, including program implementation designs that allow 
for rigorous testing of strategies.
Conclusions
Cervical cancer prevention and control has recently grabbed the headlines 
in India, with the prime minister calling for the development of a national 
cancer screening framework and the launch of a program within the 2016–17 
financial year.22 Such a program should draw on the existing evidence that 
points to a comprehensive, women-centered approach to screening and 
treatment. 
Drawing on the insights from our literature review and qualitative study, 
RTI hosted a high-level symposium on catalyzing cancer prevention in India 
in 2015.23 In addition, we are engaging in research to develop multilevel 
interventions involving communication about behavior and social change to 
advance comprehensive cervical cancer prevention and control, and we are 
creating tools to measure and evaluate the impact of such interventions. As 
part of this research, we are working closely with Indian state governments, 
cancer institutes, and global and national or local nongovernmental 
organizations. Many more such efforts can generate the much-needed evidence 
about what works to prevent morbidity and mortality caused by cervical 
cancer in India.
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Key Findings and Lessons Learned
• A range of factors operating at the levels of the individual, family, community, and 
health system facilitate or pose barriers to cervical cancer screening and follow-up.
• Women’s knowledge about cervical cancer and disease prevention, perception of 
susceptibility, family history of cervical cancer, and perceived severity of the disease 
were associated with screening intentions or behaviors.
• Lack of husbands’ support because of misconceptions about screening or treatment 
or other factors (e.g., sex of the health care provider) was a barrier.
• Being able to go for screening with friends or having a friend who had undergone 
screening was a facilitator.
• At the health systems level, offering private, respectful, and confidential screening 
by female health care providers was key to promoting service utilization.
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Characteristics of the literature reviewed on barriers and facilitators to cervical cancer 
screening and follow-up
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Characteristics of the literature reviewed on barriers and facilitators to cervical cancer 
screening and follow-up
Author and 
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Notes. FG = focus group; IDI = in-depth interview; KQ = key question. 
The four key questions (KQs) for our review focused on the facilitators and barriers to cervical cancer 
screening (KQs 1 and 2) and post-screening follow-up (KQs 3 and 4). We focused on the four levels of actors 
(i.e., individual, family, community, and health care system).
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Introduction
Noncommunicable diseases (NCDs) accounted for 63 percent of human 
mortality worldwide in 2008, and the rate is increasing.1 Given the increasing 
prevalence of NCDs around the world, countries are designing health 
programs to prevent onset or treat complications of these diseases to reduce 
the resulting health and financial burden on their societies. Apart from the 
challenges to obtain resources to develop these programs (funds, personnel, 
and capital investments), implementation challenges such as achieving high 
participation rate and compliance are also a concern. Consequently, the impact 
of these programs depends on economic and social processes, as well as on the 
efficacy of the program itself.
Geospatial, dynamic microsimulation is an ideal tool for two purposes in 
addressing NCDs: (1) to analyze a complex web of interrelated factors and 
(2) to develop an understanding of what programs or policies might work 
better than others. As part of a prior study, RTI International staff developed 
a tool, Forecasting Populations (FPOP),2 to assess the impact of population 
aging on diseases with long latency periods and to link it to the actions and 
health status of the individual. The context for such analyses involves various 
characteristics and factors: personal (age, sex, education, and similar factors), 
social (family and community), economic (family income and community 
wealth), and location (proximity to program facilities).
Dynamic microsimulation models offer the flexibility to investigate, for 
example, interrelationships among individuals (e.g., sexual behavior and 
treatment compliance), causal factors (treatment effectiveness), and disease 
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traits (secondary infection rates and genetic mutation rates) over time.3,4 The 
models then enable users to examine the influence of changes in demographic 
and social characteristics as the population’s age distribution, composition, 
and size change as a consequence of the health policy being examined. For 
example, low birth weight (LBW) is caused by nutrition deficiencies related 
to poor diet or diarrheal infections. A model of the type described here could 
assess the relative effectiveness of nutrition supplementation programs versus 
sanitation improvements.
This study had two main purposes. One was to test the feasibility and utility 
of microsimulation models for examining the impact (or lack of impact) of 
clinical or public health interventions over time. These interventions were 
intended to tackle two difficult NCD-related problems: adult obesity and 
neonatal LBW. The other purpose of the study was to produce some useful 
information for health policy makers about interventions that might be worth 
considering.
Because this project was part of an RTI Grand Challenge concerning 
low- and middle-income countries (LMICs), we needed data and potential 
interventions for an LMIC country where both adult obesity and neonatal 
LBW were prevalent and worrisome and where data were available to populate 
the assumptions required for the microsimulation models. Because we 
had recently created a baseline set of population and demographic data for 
Indonesia, that country became our focus.
The study, which was complex, produced some forecasts of trends in 
both conditions in Indonesia and investigated the impact of two clinical 
interventions over time. The investigations limited their outcomes to 
(1) examining the feasibility of applying microsimulation methods to the 
NCDs and determining how well the models performed, (2) assessing the type 
of data that would be needed to develop appropriate model parameters, and 
(3) determining the type of policy interventions that could be addressed with 
this model.
The Nutritional Paradox: Obesity and Low Birth Weight
Studies have correlated obesity with many chronic conditions, including type 2 
diabetes, cardiovascular diseases, several types of cancer, musculoskeletal 
disorders, sleep apnea, gallbladder disease, sexual dysfunction, nonalcoholic 
fatty liver disease, and asthma.5-8 Numerous studies have also found that obese 
women have a higher risk for pregnancy complications.9
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For many LMICs, the traditional problems of undernutrition run the risk 
of being dwarfed by the health problems caused by obesity.10 In developing 
countries, obesity has been linked with abundance. This observation suggests 
that as developing countries improve their economic status and their gross 
national product, undernutrition should decrease, and obesity should begin to 
appear among members of the upper socioeconomic classes.11 The relationship 
between gross national product and overweight is complex, however. Being 
poor in the poorest countries (those with a per capita gross national product of 
less than US$800 per year) appears to “protect against” obesity; however, being 
poor in a middle-income country is associated with a higher risk of obesity 
than being richer in the same country is.10
A manifestation of this nutritional paradox is the common occurrence of 
underweight children and overweight adults in the same family. This is a new 
phenomenon in developing countries undergoing the nutrition transition. It is 
apparently brought about by changes in diet, food availability, and lifestyle that 
occur in countries experiencing a socioeconomic and demographic transition.
Nutritional processes that occur as part of the human growth and aging 
process regulate four interrelated conditions: (1) LBW newborns, (2) stunting 
in neonates, (3) childhood obesity affecting children older than 2 years of age, 
and (4) adult obesity. Investigating links among these four stages has become 
a focus of research in the past 20 years. Some researchers have suggested a link 
between fetal development and obesity later in life. In one study, researchers 
found that altering the levels of two common hormones, insulin and leptin, in 
utero changed the cellular development in the region of the brain that regulates 
appetite.12 Hence, altered levels of leptin and insulin may have marked effects 
on brain development in offspring; this finding provides further clues to the 
causes of obesity.12 LBW has been associated with several chronic diseases in 
adults, including hypertension, diabetes mellitus, and obesity.13
The Current Situation in Indonesia
These results emphasize the need to prevent growth retardation by 
promoting prenatal care and breastfeeding and controlling infectious 
diseases. Consequently, we developed a model that portrays the burden of 
undernutrition and its potential influence on the epidemiology of obesity. We 
chose Indonesia as the country of focus for several reasons: we had previously 
developed a simulated baseline population for Indonesia, which could be 
used to populate our model; Indonesia has significant LBW and obesity 
issues; there is a unique longitudinal data source for Indonesia;14 and we have 
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several in-country collaborators. In addition, Indonesia is in the process of 
establishing a comprehensive national public health policy. A model like the 
one presented here could help health planners design specific policy features 
for future health care requirements.
Obesity: Epidemiology
Obesity is a serious problem in Indonesia. The current estimate is that 
67 percent of Jakartans are overweight or obese.15 Across the entire country, 
obesity has increased in all population groups, including rural and low-income 
strata, over the past 20 years.15 Using cutoff values appropriate for an Asian 
population16 to define obesity, the proportion of the population that is obese 
increased from about 8 percent in 1993 to 17 percent in 2007. (The percentages 
differ depending on the cutoff values used; however, the trend is apparent in all 
situations.) The portion of the population presenting symptoms of pre-obesity 
(weight gain, high blood pressure) has increased from 20 percent to 26 percent 
in the same 14-year period. The 2010 Indonesia Basic Health Research 
(Riset Kesehatan Dasar, or RisKesDas) Study indicates that the problem has 
continued; in 2010, 22 percent of the population older than 18 years were 
obese.17,18
Numerous health policy alternatives have been proposed to address obesity. 
These include the following approaches: 
• changing behaviors (e.g., nutrition awareness and food choices, exercise 
participation) 
• improving access to ideal nutrition (e.g., availability of nutritional 
supplements or fresh fruit and vegetables) 
• improving treatment availability and quality (e.g., establishing more local 
clinics in addition to tertiary health centers)  
• implementing monetary incentives (e.g., tax on certain foods, tax 
incentives to lose weight, or subsidized selected foods). 
Key strategies focus specifically on nutrition and food choice education, 
treatment availability, nutritional supplements, food subsidies, food taxes, and 
exercise programs and facilities.
Low Birth Weight: Epidemiology
Maternal nutritional deficiencies at conception and during pregnancy are 
associated with an increased risk of LBW and childhood stunting.19 Globally, 
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approximately 16 percent of all live births, or nearly 22 million newborns, 
weigh less than 2,500 grams (the definition of LBW). LBW is the single 
most important factor influencing neonatal mortality and is a significant 
determinant of infant morbidity and mortality.
Because maternal undernutrition is a major determinant of LBW in 
developing countries, high rates of LBW should be interpreted not merely as 
indicators of undernutrition, morbidity, and mortality for the newborn but 
also as an urgent public health warning that women of childbearing age are 
undernourished.20,21 Furthermore, research demonstrates that after 2 years 
of age, stunting brought on by LBW occurrences is difficult to reverse. Also, 
over the life cycle, these children have a greater likelihood of becoming obese 
and developing chronic disease as adults.22 Unless these trends are studied and 
appropriate public health responses are employed, a health disaster of diet-
related NCDs will unfold, with the poorest patients suffering the most because 
they will not be able to afford treatment.23
Microsimulation Models to Evaluate LBW and Obesity Trends
As a first step, our focus was on developing a model for each condition with 
the goal of connecting LBW and adult obesity in a comprehensive model in the 
near future. In its current form, our study demonstrated the following:
• Microsimulation models of LBW and obesity can be useful tools in the 
hands of appropriate policy makers.
• Studies can measure regional and national impacts of clinically specific 
interventions.
• Patients will participate in nutrient-based intervention programs if they 
have access to clinics that support the intervention.
• Static clinical data sources limit the type of investigations that can be 
accomplished by a simulation model. The Indonesia Family Life Survey 
(IFLS)14 is a longitudinal data set that can be used to measure changes 
in patients’ characteristics and their environment as they age. Hence, 
IFLS can be useful in investigating the ramifications of LBW and the 
connections between LBW and adult obesity.
The effectiveness of health policy interventions depends both on whether 
the Indonesian health care system provides diagnostic, preventive, and 
treatment services and on individual patients’ willingness to use those 
services and participate in health programs. To assess participation rates, we 
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collaborated with researchers at SurveyMETER (http://www.surveymeter.org) 
to design and implement a survey to measure mothers’ willingness to 
participate in a nutrition supplement program. This survey is described in the 
Methods section under “Preference Survey to Estimate Participation Rates for 
the Low Birth Weight Model.”
Table 3.1 presents the primary questions we sought to address in this study.
Table 3.1  Study issues addressed by the Indonesia models
• How prevalent will obesity and low birth weight (LBW) be in the next 50 years in 
Indonesia?
• What possible unintended consequences (such as high clinic utilization) will obesity or 
LBW cause?
• How effective will the interventions be for reducing obesity and LBW profiles?
• How effective will the interventions be for reducing obesity- and LBW-related conditions?
Methods
The Microsimulation Models
For this project, we took an existing microsimulation framework tool called 
FPOP (Forecasting Populations)2 that we developed before this study and 
linked it to Indonesian population “synthetic” data.24 We then added program 
logic to represent two separate conditions—LBW and adult obesity—to 
simulate the population aging process, while simultaneously tracking changes 
in obesity and LBW patterns. Although we developed the baseline data for all 
of Indonesia, we limited our analysis to the provinces of Yogyakarta and Bali. 
This limited focus permitted a more thorough verification of the changing 
weight patterns and intervention policies occurring against a backdrop of an 
aging population.
Forecast Populations Tool Overview
FPOP is a dynamic, discrete-time microsimulation model that incorporates 
links among life events, changes in household structure, and changes in 
the attributes of individuals and their location as part of the aging process. 
Individuals can be tracked over the life course for decades.2 The life events 
that modify households and populations include birth, marriage/union 
formation and dissolution, migration, aging, and death. The model determines 
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the occurrence of life events at each discrete time step stochastically, using 
empirically derived transition probabilities.
We calculated the initial transition probability parameters for FPOP using 
Indonesian national census data and health information data. The FPOP 
model linked to an existing, spatially explicit synthetic baseline population 
that represented the Indonesian household population in 2010. The baseline 
population provided the households and persons for whom FPOP simulated 
and projected life events.
One major advantage of microsimulation models is their ability to examine 
the effects of alternative scenarios over time. Such scenarios are useful for 
understanding the sensitivity of key outcomes to demographic or policy 
changes. For example, one can use microsimulation methods to examine the 
future population distribution under different demographic or social scenarios 
or to estimate the long-term performance of various programs or policies.
FPOP’s life event probability tables are easily modifiable either to 
test existing policy scenarios and existing demographic trends or to test 
hypothetical policy and demographic scenarios. These life event probabilities 
are common to all birth-death population scenarios. We added LBW and 
obesity attributes to the simulated population so that we could assess how 
patterns external to FPOP would affect the population projections.
In general, the availability of appropriate data limits this type of 
approach. Accordingly, we used several approaches to obtain data to set 
the parameters for our model. Sources included RTI’s Indonesia synthetic 
population, Indonesian census data, and IFLS data.14,24,25 One key model 
parameter was intervention participation. Specifically, we needed to be able 
to predict the proportion of females who would participate in the LBW 
intervention. Accordingly, we developed and fielded a preference survey (with 
SurveyMETER) that targeted women of birth age to simulate a micronutrient 
supplementation intervention. This intervention reported a 16 percent 
reduction in LBW, as described by Bhutta et al.26 The results of the survey were 
used to identify which women would participate in the intervention.
The microsimulation discussed in this chapter was based on an initial 
synthetic population in which each individual is described by several 
characteristics. These include, but are not limited to, sex, age, race, ethnicity, 
education, and family type.
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Table 3.2 lists the various characteristics required, the source of the data, 
and the geographic level of detail for the simulated data set. The product of 
these data is an initial synthetic population of Indonesia that represents each of 
the 61.4 million households and 237.6 million people in that country.
Obesity Model Overview
A major assumption behind the obesity model application is that the body 
mass index (BMI) measure indicates adult nutritional status. (BMI is a person’s 
weight in kilograms divided by his or her height in meters squared.) The US 
National Institutes of Health (NIH) now defines normal weight, overweight, 
and obesity according to BMI. A second assumption is that changes in BMI 
reflect changes in overall levels of obesity. Thus, predictions of future numbers 
of people with high BMIs are used to assess the effectiveness of obesity 
prevention programs and, accordingly, provide the effectiveness component of 
a cost-effectiveness analysis. In addition, the predictions will indicate to both 
policy makers and the community at large the potential scale of the obesity 
epidemic and whether hypothetical interventions are likely to be effective in 
limiting the epidemic.
The first step in the process was to assign the baseline height and weight 
for adults by age and sex from the 2007 IFLS (hereafter “IFLS2007”) to the 
baseline synthetic population.14 Because the Indonesian synthetic population 
does not contain BMI, height, and weight as characteristics assigned to each 
person, we used the IFLS2007 survey, which does contain measures of BMI, 
height, and weight for each survey respondent.
We summarized these key variables by age, sex, and urban or rural location 
to determine the mean, maximum, minimum, and standard deviation values 
by demographic covariate. Also, we summarized the distribution of weight 
Table 3.2   Demographic characteristics applied as parameters to the Indonesian 
synthetic population
Characteristic Source of estimate Geospatial level of estimate
Demographics of synthetic 
population
IPUMS 201027 Regency (i.e., a political 
subdivision of a province)
Household location LandScan 201228 1 kilometer cell unit
Height IFLS200714 Province
Weight IFLS200714 Province
Sources: International Public Use Microdata Series (IPUMS 2010)27; LandScan28; Indonesia Family Life 
Survey 2007 (IFLS2007).14
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in each BMI range (using the WHO eight-category BMI standard definitions 
shown in Table 3.3). Then we assigned weight to each synthetic person based 
on the distributions by age, sex, and urban/rural location. Next, based on the 
assigned weight for each individual, we estimated and assigned a BMI value to 
each individual. Having assigned a BMI and weight value for each individual, 
we then solved for height and assigned a height to each synthetic person.
The simulation phase assigned adult persons an annual weight change in 
kilograms. The model assumed height to be constant for each individual man 
or woman for the duration of the simulation. The subject’s age, sex, and BMI 
determine which weight distribution to use in this calculation. In this case, we 
used the weight trajectories for this calculation derived from US data.29 We 
took the baseline weight value for men and women and simulated an annual 
weight change every year. Every year, each individual’s weight change was 
sampled from a normal distribution with a mean annual weight change and 
standard deviation estimated from IFLS2007 by sex and urban/rural location. 
The yearly percentage changes were assumed to be between −0.5 BMI units 
and 2.0 BMI units and no greater than 10 percent of the current weight. The 
minimum BMI was set to 16.
Finally, we introduced a behavioral intervention to reduce the level of 
obesity in the adult Indonesian population. A literature search revealed that 
scant evidence exists for obesity interventions within Indonesia. Because of 
this lack of evidence, our intervention assumed the structure of a general 
Table 3.3  The international classification of adult underweight, overweight, and 
obesity according to BMI
Octile Classification Body mass index (BMI) (kg/m2) range
1 Severe thinness < 16.00
2 Moderate thinness 16.00–16.99
3 Mild thinness 17.00–18.49
4 Normal 18.50–24.99
5 Pre-obese 25.00–29.99
6 Obese class I 30.00–34.99
7 Obese class II 35.00–39.99
8 Obese class III More than 40
Source: World Health Organization, 2016.16
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behavioral treatment based on an example reported by LeBlanc and colleagues 
that targeted behavioral interventions involving overweight or obese US 
adults.30 The advantage of this assumption is that the authors examined a 
broad array of interventions, ranging from physical activity to cognitive 
therapy.30 The resulting effect sizes were moderate: a 3-kilogram loss (2–4 
kilograms, 95 percent confidence interval [CI]) between 12 and 18 months. We 
simulated their reported effect size for 1 year.
To implement an intervention, a subset of the “simulated” persons 
participate and as a consequence reduce their BMI by 3 kilograms (2–4, 
95 percent CI) for 12 months during the intervention phase. After the 
intervention and maintenance period, the pre-intervention weight trajectory 
resumes. Over time, changes to nutritional state occur as changes to BMI 
occur. When BMI levels dictate, persons move into new nutritional categories. 
As time advances, subjects move to new BMI categories according to the 
change in their BMI projections. Table 3.4 summarizes parameter estimates 
and statistical model assumptions used in the obesity model.
Table 3.4  Parameters and sources of estimates for the obesity model
Parameter








Indonesia Family Life 
Survey14
Sample from normal 















maternal and child 
nutrition: what can 
be done and at what 
cost?26
Annual mean change Initial BMI category
BMI = body mass index. 
Sources: Indonesia Family Life Survey 2007 (IFLS2007)14; National Longitudinal Survey of Youth (NLSY79), 
Table 329; US Preventive Services Task Force.30
Low Birth Weight Model Overview
The probability of a LBW birth comes from two sources (see Table 3.5). The 
first source is the Health at a Glance tables compiled by the Organisation 
for Economic Co-operation and Development (OECD).31 A second source 
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is the Indonesia Demographic and Health Survey (DHS), sponsored by 
the US Agency for International Development (USAID).32 Although the 
DHS provides a much lower national figure for LBW, it is also stratified by a 
number of relevant cofactors including parity, birth order, and urban/rural 
location. Accordingly, we used the DHS estimate to examine the trends in 
LBW 50-year profiles without and with the food supplement intervention. 
We factored into the simulation process the mother’s probability of having 
participated in an intervention during her pregnancy, which is based on the 
responses to the preference survey. (We report these results in the following 
section.) Statistically significant variables from the analysis of the survey that 
influenced the LBW simulation results include distance from the intervention 
site and age of the mother. If the mother did participate in the intervention, the 
adjusted probability of an LBW birth replaced the DHS estimate.
Preference Survey to Estimate Participation Rates for the Low Birth Weight 
Model
A key variable that is unavailable from any known source is the proportion 
of women that would participate in a nutrient supplementation intervention. 
To obtain an estimate of this variable, we conducted a preference survey in 
collaboration with SurveyMETER, a nongovernmental research institute 
based in Yogyakarta, Indonesia. SurveyMETER staff cooperate with 
other institutions, policy makers, and researchers both domestically and 
internationally to design, plan, and implement high-quality data collection. 
RTI analysts developed the initial survey plan and designed the survey, and 
Table 3.5  Parameter and source of estimates for low birth weight model
Parameter Source of parameter estimate Explanatory variables
National LBW estimate OECD compilation of indicators 
from a number of sources including 
international Health Accounts experts, 
the World Health Organization, and the 
World Bank31
Country





SurveyMETER Survey probit regression Distance to clinic and 
age of mother
LBW = low birth weight.
Sources: Organisation for Economic Co-operation and Development (OECD)31;  
US Agency for International Development (USAID).32
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SurveyMETER contributed to the design and carried out all of the field 
operations.
Initially, the survey presented the respondents with a description of a 
hypothetical food supplementation program, which was based on programs 
found to be effective in reducing the risk of LBW deliveries.33 The survey 
described the program as lasting 1 year and entailing monthly visits to a 
specialized health center to receive a month’s supply of daily food supplements. 
As part of the program, health workers would provide advice on preparing 
healthy meals and would collect anthropometric measurements every 3 
months. The program would be provided at no cost.
To model a woman’s willingness to participate (i.e., her demand for 
the program), we created a model based on a standard random utility 
framework.34,35 We measured respondent demand using a single-bounded 
discrete-choice valuation question (i.e., “Would you [name of participant] 
agree to participate in this food program?”).
Because programs providing daily food supplements are not widely 
available in Indonesia, we used a contingent valuation method to collect data 
on intervention participation. This method, which measures respondents’ 
preferences for currently unavailable goods,36 is now widely used in 
developing countries.37,38 The contingent valuation component of our survey 
asked respondents about their willingness to participate in a hypothetical 
food supplementation program given a range of possible one-way travel 
times to the program’s health offices. The survey told respondents that they 
would be required to pay their own travel expenses and they could experience 
one-way travel times of 10 minutes, 30 minutes, 60 minutes, or 120 minutes. 
Each travel time was included in the study design. Each respondent was 
randomly assigned to only one travel time. Our total original sample size 
of 200 was based on a goal of approximately 50 completed interviews per 
experimental travel time. (The survey also asked respondents about their 
willingness to enroll their children younger than the age of 2 years in the same 
hypothetical food supplementation program, but these data are not analyzed 
or reported here.)
Sampling Plan and Procedures
The study aimed to conduct 200 household interviews in eight enumeration 
areas located in two provinces from Java, the most populated island. The 
provinces were Central Java and Special Region DI Yogyakarta.  The sample 
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was stratified by urban/rural status. The urban enumeration areas were 
randomly selected from two cities, Semarang (the capital of Central Java) and 
the city of Yogyakarta (the capital of DI Yogyakarta). The rural enumeration 
areas in DI Yogyakarta were selected from the other districts in DI Yogyakarta, 
whereas the rural enumeration areas in Central Java Province were selected 
from a list of rural villages located in two districts bordering Semarang: 
Semarang district and Kendal district.
SurveyMETER selected households from lists of households with children 
younger than 2 and mothers between 18 and 38 years of age acquired from 
each selected village. Twenty-six households were randomly chosen from each 
enumeration area’s household list. Each selected household was randomly 
assigned to one of the four questionnaire versions based on one-way travel 
times. All survey interviews were administered by trained interviewers from 
SurveyMETER. Completed interviews were electronically submitted to the 
SurveyMETER office in Yogyakarta, where they were reviewed for data quality; 
errors were reported to the field team for correction.
The study protocol was reviewed and approved by institutional review 
boards at RTI and SurveyMETER. In addition, permission to conduct the 
study was also provided by the Government of Indonesia.
Results
Survey Estimates for Participation Rates
We analyzed the survey data using several probit regression models to 
determine which variables best explained the respondents’ stated willingness 
to participate in the hypothetical food supplementation program. The findings 
from this survey indicated that the location of a respondent’s residence 
had a statistically significant effect on stated willingness to participate, but 
whether the respondent lived in a rural or urban area was not statistically 
significant. Whether the respondent had moved to a new regency or province 
in the 5 years prior to the survey did not influence mothers’ willingness to 
participate. Neither did household income, access to better quality drinking 
water, household size, or ownership of select assets. However, respondents 
with the following characteristics were less likely to say they would participate: 
those without a telephone, respondents who owned a motorbike or motorboat, 
and respondents participating in a state-sponsored poverty alleviation 
program. 
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Respondents with a BMI of less than 18.5 (an indication of underweight) 
were more likely to say they would participate in the hypothetical food 
supplementation program. However, other variables potentially indicating 
the respondent’s need for supplemental nutrition (i.e., whether or not the 
respondent was breastfeeding at the time of the survey, had previously given 
birth to a LBW baby, had participated in a food supplementation program 
in the past, or had a family history of underweight) did not provide much 
explanatory power. 
Younger women were more likely to say that they would participate in the 
program. Respondents who were over the age of 19 years were less likely to say 
they would participate than respondents under the age of 18. 
Overall, 74 percent of women reported that they would be willing to 
participate in the food supplementation program. Willingness to participate 
declined significantly as the one-way travel time increased (p < .001). Although 
94 percent of women with an estimated 10-minute one-way travel time and 
88 percent with a 30-minute travel time reported that they would participate in 
the program, the percentage dropped to 67 percent with 60 minutes of travel 
and to 46 percent with 2 hours of one-way travel.
Probabilities of participation were estimated by travel time to the 
intervention site and mother’s age. Distance, age, size of housing, motorcycle 
ownership, and presence of a telephone in the house were strong predictors 
of participation. We set probabilities for mothers older than 38 equal to those 
for ages 35 to 38 years for the same travel time. All other variates were set to 
the mean values for the population. Table 3.6 shows the probabilities, which 
ranged from about 0.1996 to 0.9997. The youngest women (under age 20) 
were more likely to report that they would participate regardless of travel 
time. Up to 30 minutes of one-way travel had relatively little effect on women’s 
Table 3.6  Probability of participation in food supplementation programs by age of 










18–19 years 0.9997 0.9986 0.9884 0.7945
20–24 years 0.9855 0.9554 0.8356 0.3190
25–29 years 0.9959 0.9845 0.9243 0.4949
30–34 years 0.9649 0.9078 0.7271 0.1996
35–38 years 0.9856 0.9558 0.8366 0.3204
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willingness to participate, regardless of age. An estimated travel time of 
120 minutes significantly reduced women’s likeliness to participate across all 
age groups.
Low Birth Weight Model Results
Findings for Incidence of Low Birth Weight Assuming No 
Intervention
We ran the LBW models for the Yogyakarta and the Bali provinces for 50 years 
with no intervention (see No Intervention columns for each province in 
Table 3.7). As expected, the LBW incidence did not change appreciably over 
the 50-year time period. With no food supplementation intervention, the 
projected percentage of births that would be LBW births slightly declined 
for Yogyakarta (7.02 percent to 6.83 percent after 50 years), but the projected 
percentage of LBW births increased slightly over the same time period for the 
Bali population (6.92 percent to 7.06 percent).












2010 7.02 6.23 6.92 6.28
2015 6.98 6.37 6.82 6.27
2020 6.77 6.32 6.96 6.12
2025 7.16 6.19 7.14 6.24
2030 6.93 6.17 6.77 6.20
2035 6.85 6.19 6.96 6.06
2040 7.02 6.20 9.95 6.29
2045 6.87 6.17 6.96 6.06
2050 7.00 6.35 6.97 6.23
2055 6.83 6.21 7.06 6.03
Note that the baseline fertility rates were lower in Yogyakarta (1.94 births 
per 1,000 women aged 15–44 in a calendar year) than in Bali (2.13 births per 
1,000 women).39 Consequently, estimated population growth in Bali grew by 
30 to 40 percent over the projected time period. By contrast, in Yogyakarta, 
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overall population growth was 14 percent over the same time period. These 
findings indicate that unless immigration is significant, by 2055, Yogyakarta 
will have an older population.
Findings for Incidence of Low Birth Weight Assuming an 
Intervention and Variable Participation Rates 
When we introduced into the model the participation rates shown in Table 3-6, 
the reduction in LBW incidence was modest (see Table 3-7). In Yogyakarta, 
LBW incidence went down 11.3 percent in the first year (from 7.02 percent to 
6.23 percent). This reduction dropped to 9 percent (from 6.83 percent to 6.21 
percent) in 2055. In Bali, the decrease in LBW incidence was 9.2 percent in 
year 2010 and increased to 14.6 percent in year 2055. Note that participation 
rates were slightly lower in Bali reflecting the slightly longer travel times in Bali 
relative to Yogyakarta to the clinics that administered the intervention.
Obesity Model Results
Unlike the LBW model, no participation rate estimates were available for 
the obesity model, and we did not develop a survey to obtain an estimate of 
obesity intervention participation. Consequently, we simulated participation 
rates of 0, 25, 50, 75, and 100 percent, all beginning from the baseline year 
(2010) estimate. The results can be viewed as a sensitivity analysis of the 
participation rate estimates. 
The WHO defines eight weight categories based on the BMI classifications 
shown in Table 3-3 earlier in the chapter. We stratified our population into 
these eight BMI categories (three classifications of thinness; normal; pre-obese; 
and three classifications of obesity).
We assumed that participation in the behavioral intervention yielded a 
modest mean weight loss of 3 kilograms distributed over a 1-year period plus a 
1-year maintenance period. All year-long intervention or maintenance periods 
started at the baseline year (2010). We assumed further that individuals 
resumed their previous annual weight trajectory after completing the 
intervention period. The participants in the intervention were the pre-obese 
and obese individuals identified in the model as persons with a BMI greater 
than 27.5.
Table 3.8 shows the baseline BMI distribution (percentage of total) in 
Yogyakarta, by age group and BMI classification. 
When we ran the model for 30 years without the intervention (see 
Table 3.9), the projected obesity rates increased substantially over the 30-
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year period. For example, the frequency of obese individuals (categories 6–8) 
ages 45 to 54 years rose from 7.63 percent (6.95 + 0.66 + 0.02) to 9.84 percent. 
In the oldest group (ages 65 or older), the increase of overweight and obese 
subjects (categories 5–8) more than doubled, from 14.55 to 29.73 percent. In 
contrast, at the start of the simulation, almost 60 percent of the women in the 
youngest age group had normal BMI; after 30 years, with no intervention, this 
number was reduced to 57 percent.
Table 3.8  Distribution of adults in Yogyakarta across obesity classifications, by age 
group: year 0
Age Groups
BMI Classification 25–34 35–44 45–54 55–64 65–100
Severe thinness 2.12% 0.92% 1.55% 2.89% 4.98%
Moderate thinness 2.95% 1.76% 2.21% 3.12% 5.60%
Mild thinness 7.72% 5.53% 5.94% 7.7% 13.57%
Normal 59.66% 53.76% 54.00% 55.96% 61.31%
Pre-obese 23.69% 30.37% 28.67% 24.75% 13.12%
Obese class I 3.61% 6.93% 6.95% 5.10% 1.35%
Obese class II 0.24% 0.69% 0.66% 0.46% 0.06%
Obese class III 0.01% 0.04% 0.02% 0.02% 0.01%
Total 100.00% 100.00% 100.00% 100.00% 100.00%
Table 3.9  Distribution of adults in Yogyakarta across obesity classifications, by age 
group: year 30, with no intervention
Age Groups
BMI Classification 25–34 35–44 45–54 55–64 65–100
Severe thinness 0.41% 0.20% 0.35% 0.57% 0.65%
Moderate thinness 5.56% 3.51% 4.27% 6.24% 11.70%
Mild thinness 7.40% 5.33% 5.72% 7.29% 11.92%
Normal 56.74% 50.94% 50.02% 52.09% 46.00%
Pre-obese 24.91% 30.56% 29.80% 25.85% 17.18%
Obese class I 4.58% 8.33% 9.10% 6.96% 6.02%
Obese class II 0.38% 1.05% 0.66% 0.95% 2.72%
Obese class III 0.02% 0.08% 0.08% 0.05% 3.81%
Obese class III 0.01% 0.04% 0.02% 0.02% 0.01%
Total 100.00% 100.00% 100.00% 100.00% 100.00%
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We also ran simulations with varying rates of participation to compare the 
effects of increasing participation rates in the intervention. Simulations like 
this can demonstrate to decision makers what target participation rate would 
be needed to offset the natural rise in BMI rates that would occur naturally (as 
Tables 3.8 and 3.9 reflect).
We combined the population of adults older than 24 years of age from the 
two provinces and then separated that group by male vs. female and by urban 
vs. rural location. Figure 3.1 presents the average BMI of the groups over a 
30-year period in the absence of an intervention.
The growth curve of average BMI for females approximates the curve for 
males; the same growth pattern holds for rural and urban adults. Figure 3.2 
compares the average BMI profiles of males and of urban adults over 30 
years under no intervention from Figure 3.1 (baseline) with the profiles of 
those groups after 30 years if 25 percent of the adult population participated 
in the intervention. For simplicity of presentation, we dropped rural adults 
and females from Figure 3.2, since both groups respond to the intervention 
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in a manner consistent with urban adults and males. Over the 30-year 
simulation period, an intervention involving 25 percent of the participation 
approximately flattens out the growth curve of average BMI for all groups 
examined compared with preintervention levels. In other words, a 25 percent 
participation would maintain the status quo.
Discussion
Our Modeling Approach
A major goal of our study was to demonstrate that by wedding an external 
disease or condition to the FPOP framework, we could produce a robust 
model capable of performing intervention assessments. We demonstrated this 
capability for two conditions: LBW and obesity. As documented earlier, these 
conditions are problematic in Indonesia specifically and in LMICs generally. 
LBW births and obesity are both major risk factors for numerous chronic 
diseases, including diabetes, cardiovascular diseases, and cancer. Thus, they 
both appeared to be appropriate choices, and we decided to implement both.
Figure 3.2  Average urban and male adult BMI over 30 years, by year: 
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Eventually, we realized that the two conditions were related in the sense 
that it is common for survivors of LBW to become obese as adults. The 
linkage between the two conditions is a third condition—namely, stunting 
(below −2 standard deviations from median height for age of the reference 
population). This condition can occur at birth or can develop during 
preadolescence, but examining it was beyond the scope of this pilot project for 
the RTI Grand Challenge. Consequently, we developed the two models but did 
not attempt to connect them.
Our modeling approach was a natural mechanism for testing hypotheses 
regarding LBW and obesity projections. In addition, we provided examples 
that demonstrated how users of FPOP could integrate interventions into the 
models.
Apart from the epidemiology and risks of these disorders in Indonesia, we 
selected Indonesia because of two other factors: RTI International maintains a 
formal regional office in Jakarta, Indonesia, and we had good contacts within 
the country. One of these contacts was SurveyMETER, whose staff became 
part of the study team and with whom we developed a collegial partnership.
Impact of Interventions
The specific impacts we simulated in the two FPOP models were 
straightforward exercises. In the case of the LBW model, our results 
demonstrated that the effectiveness of an intervention depends on the initial 
birthrate and the regional and demographic factors that influence LBW 
occurrences. The specific intervention was based on a highly regarded clinical 
study that had been designed to limit the occurrence of LBW. This particular 
example demonstrated one of the features of a FPOP-type model; namely, 
to take the results of a clinical trial and extend the trial results to a target 
population. In the case presented here, LBW births, as reported in the DHS 
survey,32 are sufficiently low that the intervention demonstrated little impact.
The obesity model demonstrated that if the status quo prevails in Indonesia 
(i.e., that the weight gain patterns continue as they have since 2007), the 
obesity profiles in Indonesia reflect disturbing trends. Large future weight 
gains are predicted for both men and women living in both urban and rural 
areas. Offsetting these baseline weight gains would require a national campaign 
involving exercise and food choices, and such a campaign would need to be 
sustained over a 30-year time period.
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Application of the Microsimulation Models
All computer models are simplifications of reality. They can never account 
for every possible factor or interaction. For that reason, our current results 
likely underestimated the consequences of the obesity epidemic and the LBW 
problem. However, our obesity model demonstrated that continuing high rates 
of obesity among the working-age population may adversely affect national 
productivity and contribute to negative health consequences for a rapidly 
growing Indonesian population.
What our exercise produced is a model that in the right hands can be a 
valuable planning tool for managing a worrisome problem that is becoming 
more prevalent in developing countries generally. This model can be applied 
to any country that has comprehensive data with which to generate both the 
baseline synthetic population and the parameter estimates for the disease 
models.
Our version of the model addressed obesity and LBW. However, the 
model can incorporate any addressable noncommunicable disorder and, if 
appropriate, definable prevention and treatment programs.
The Future
No single model currently exists that accommodates the individual (e.g., 
nutrition), household (e.g., parent education), and community (e.g., 
sanitation) risk factors that determine physical growth and development 
throughout the life stages of Indonesians or any other LMIC. The rapid 
technical, environmental, and economic changes taking place across the 
landscape of developing countries are dramatic and will have major future 
health consequences.
Various clinical and epidemiological studies examine associations between 
single risk factors (e.g., maternal nutrition) and stunting or obesity. No model 
yet exists for evaluating simultaneously how the complex interplay between 
individuals and the environment affects stunting and obesity risk. Our model 
is the beginning of that development.
Applying our model can pave the way for improving the health of children 
and adults of future generations by connecting the two models to target the 
double burden of malnutrition as a whole. Poor infant nutrition is a major risk 
factor for chronic diseases, in particular abdominal obesity, type 2 diabetes, 
hypertension, and cardiovascular disease.40 The model can identify policies 
for preventing LBW, stunting, and obesity across the diverse Indonesian 
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landscape. It can also identify region-specific approaches, a necessity for a 
country with limited resources and a decentralized health care system.
Conclusions
Our main accomplishments include the following:
• We developed two separate NCD models that we applied to Indonesia: 
adult obesity and LBW births.
• We linked each model to a spatially explicit, synthetic baseline population 
of Indonesians generated from a microdata sample of the Indonesian 
2010 census.
• To facilitate model development, we used an existing modeling 
framework that can be adapted to most NCD scenarios.
• We used the IFLS panel survey, census data, health surveys, and a small 
in-house survey to develop model parameters.
• We applied and demonstrated a separate intervention to each disease. 
By simulating and collecting outcome measures with and without the 
intervention, we interpreted the potential benefit of the intervention.
This experience galvanized our interest, and we are currently seeking 
processes to broaden model development.
Key Findings and Lessons Learned
• The Forecast Populations (FPOP) tool greatly facilitated model development.
• All simulation models need a baseline population to process. The synthetic data 
approach supports this process with efficiency and accuracy. 
• FPOP and synthetic data available are insufficient for modeling noncommunicable 
diseases (NCDs) without additional clinical data that describe disease-linked 
measurements and changes in those measurements because of aging. The specific 
conditions depend on the NCD.
• The two NCDs we modeled are biologically connected in the sense that being a low-
birth-weight infant increases the risk of adult obesity.
• The linkage between the two conditions is stunting. A stunted child reflects severe 
sustained malnutrition, which is difficult—and perhaps impossible—to overcome.
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Supporting Diabetes Medication Understanding 
and Adherence Through a Health Literacy 
Intervention, Meducation, in Kerala, India
Jonathan S. Wald, N.S. Vishwanath, Madhu Shrestha,  
Christine Poulos, Leena Simon, and Gadhadharan Vijayakumar
Introduction
People with diabetes need to reach and maintain health targets for glycemic, 
blood pressure, and lipid control; make sustained behavioral changes (healthy 
diet, activity, and habits—including smoking cessation and medication 
adherence);1 and follow recommended care plans over time. Only with these 
steps can patients avoid serious diabetes complications, medication side effects, 
and increased use of health resources. This is true for both developed and low- 
to middle-income (LMIC) countries.2
The explosive growth in the prevalence of diabetes in India has intensified 
the public health challenge of helping patients have and follow an appropriate 
diabetes care plan. Visit-based care for patients is an important opportunity 
for patient and family interactions with a physician. However, many 
challenges accompany visit-based care. Communication between patients 
and their care team is not always effective.3 Supporting patients in managing 
their own diabetes requires additional visit time and skills, which are often 
under-resourced.4 Individuals must use visits and other resources to develop 
sufficient diabetes knowledge, coordinate interactions with different members 
of the clinical team, and sustain their efforts and motivation over time to 
avoid diabetes-related harm.5 The Chronic Care Model developed in 1998 by 
Dr. Edward Wagner and his team6-8 highlights important activities, people, 
and systems that interact to support quality care in diabetes; it also points to 
barriers to effective management of care.
Poor adherence to medications contributes to poor outcomes among 
patients with diabetes and other chronic conditions. Barriers to adherence 
such as limited patient medication understanding or affordability (or both) can 
reduce not only adherence, but also medication safety and efficacy.9
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Health literacy, the “degree to which individuals have the capacity to obtain, 
process, and understand basic health information and services needed to make 
appropriate health decisions,”10 affects up to one-half of patients in the United 
States.11-13 Limited health literacy can prevent patients from understanding 
how to avoid a chronic condition in the first place or how to prevent a disease’s 
complications after its onset, especially in diabetes.14 Because of its effect 
on diabetes knowledge, limited health literacy is a contributing factor in 
medication nonadherence.15 If patients have limited health literacy, they may 
decide to stop taking medications unilaterally or use them with the wrong 
dose or frequency. This problem reduces the intended effects of medicines, 
and it contributes to troubling drug side effects or drug interactions that may 
not be brought to the attention of a clinician or pharmacist who can help. 
Health practitioners often underrecognize limited health literacy,12 which 
is not surprising given the limited time they have to counsel patients about 
medications.16
The concept of “universal health literacy” has been promoted to advance 
the notion that, because limited health literacy is widespread, clinicians 
should approach every patient as if health literacy challenges may be present. 
Because clear, simple language is helpful to everyone, universal health literacy 
makes sense.17 Interventions designed to expand patients’ understanding, 
to train and support physician communication about medications, and to 
improve patient self-tracking of medication use can help improve medication 
adherence and glycemic control.1,18,19 These interventions include steps to 
assess an individual’s skills and knowledge, actions to improve the suitability 
of educational materials for those with limited health literacy, and ways to 
educate patients.11 However, interventions to improve health literacy often 
require time and expertise, both of which are in short supply.
Technology can help considerably to support patient learning about 
diabetes and serve patients with limited health literacy.20,21 Advanced 
technologies to support diabetes care are increasingly used in the United States 
and other higher-resource countries in the form of electronic health records, 
personal health records, sensors (e.g., glucometers, pedometers, home blood 
pressure cuffs), and decision aids.22 Patient use of web-accessible23 and mobile 
tools at work and at home24 offer promising new approaches for fostering 
patient self-management.
One internet technology, Polyglot Systems’ Meducation (http://info.
meducation.com), provides drug information to patients in a highly 
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tailored, readable, understandable format; it serves as a universal health 
literacy intervention. It supports patients by giving them tailored yet simple 
medication information designed to maximize understanding through the use 
of pictograms, large font sizes, simple language, and language translations. For 
example, patients can see the same tailored information in Malayalam, English, 
or any of 18 other languages. Meducation supports providers by supplying 
state-of-the-art information to patients beyond what the providers typically 
have time or training to provide.
To investigate the feasibility of using this tailored health literacy 
intervention in an outpatient diabetes clinic, we designed a feasibility pilot 
to install and use Meducation at the Medical Trust Hospital (MTH) and 
Diabetes Care Centre in Kulanada, Kerala, India. The specific aim of this pilot 
project was to learn what enablers and barriers both patients and staff might 
experience in this LMIC setting, and to determine what might be needed to 
scale its use more broadly. A secondary aim was to explore whether using 
Meducation was associated with any changes in medication knowledge, 
medication adherence, diabetes learning, patient satisfaction, or glycemic 
control.
Methods
This was a mixed-methods pilot study of the introduction of Meducation into 
a diabetes clinic in Kerala, India. We sought to understand the feasibility of 
this intervention and to understand technology adoption barriers and enablers 
over a 3-month period. We also collected survey and biometric data to 
compare the potential impact of the Meducation intervention over time among 
participants who received it and those who did not.
Approach
The first 6 months of the project (April 1 to September 30, 2013) focused on 
four key prestudy activities: (1) enhancing and testing the Meducation system 
(including Malayalam translation of glucose-control medication content); 
(2) developing and translating study questionnaires, consents, and materials; 
(3) obtaining institutional review board (IRB) approval at RTI and the Medical 
Trust Hospital in India; and (4) implementing the Meducation system and 
training staff. In the next 3 months (October 1, 2013, to February 15, 2014), we 
recruited participants and collected data. Between February and April 2014, 
we analyzed and reported results.
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Collaborating Teams
This project involved collaborators within RTI and across several 
organizations. The latter included the St. John’s Research Institute in Bangalore, 
India, the Medical Trust Hospital and Diabetes Care Centre in Kulanada, 
Kerala, India, and Polyglot Systems, Inc., in Morrisville, North Carolina. 
Polyglot Systems is a small business that specializes in software tools to address 
health literacy and health communication challenges.
The MTH is a private hospital with 100 beds and an outpatient center with 
more than 150 patient visits on a typical day. The hospital is located in the 
Kulanada district, which is a semi-rural community in the more affluent and 
well-educated southern state of Kerala, India. The MTH cares primarily for 
patients with diabetes and its complications. Dr. Vijayakumar and his staff 
(including several physicians, nurses, nutritionists, and pharmacists) have 
participated in various grant-funded projects to support community outreach 
to improve diabetes education, and they are well known for successfully 
healing the feet of patients with very poor nerve conduction, circulation in the 
feet, and wound healing.
Educational Handouts
Meducation is a commercially available software product that presents tailored 
medication information in 20 languages (as of March 2016). Materials are 
written at the fifth- to eighth-grade reading levels, in large fonts. Universal 
pictographs communicate the medication schedule. It is available in either an 
online or a printed format. Meducation operates using Software-as-a-Service 
(SaaS); this requires only a web browser and internet connection, which we 
provided as part of the study.
For each project participant using a glucose-control medication, we 
entered prescription information into the system using an anonymous patient 
identifier, and we provided printouts to the patient. Meducation does not store 
any patient-identifying information on either a computer or any server. Thus, 
we had no sensitive data to protect online.
Figure 4.1 illustrates a sample Meducation patient handout presented in 
the local Malayalam language. The same handout, tailored to the patient, is 
available in each language that Meducation offers.
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Participants and Group Assignments
Study participants were adults (18 years or older) who spoke Malayalam, 
had at least one glucose control medication prescribed, were new patients 
to the MTH, and had monthly follow-up visits scheduled. Recruitment 
occurred early in the day (around 6 a.m.) as patients arrived for fasting blood 
work. The study preassigned each clinic day as an “intervention” day or a 
“nonintervention” day to minimize contamination effects. Consented patients 
completed questionnaires, had HbA1c (gycolated hemoglobin, a measure of 
average glucose over a 3-month period) included in their laboratory tests, 
and received Meducation printouts if they were assigned to the intervention 
group. We enrolled a total of 130 participants at the start of the study to 
ensure a minimum of 80 participants at its conclusion. Including the HbA1c 
measurement also helped to improve patients’ motivation to participate in the 
study (which paid for the test), because most patients self-pay for laboratory 
tests and often choose not to obtain the HbA1c even when the clinic physician 
and clinical staff strongly recommend that they do so.
Figure 4.1 Meducation handout in Malayalam
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Measurement
Figure 4.2 shows study activities during patient visits over a 3-month period. 
All participants completed study questionnaires and received an HbA1c 
test during their visits at baseline and at 3 months. One-half of the patients 
received the Meducation handouts; the comparison group did not. We 
abstracted administrative and clinical data from the medical record at baseline 
and updated that information after 3 months.
Questionnaire and Qualitative Data. The questionnaire drew items from 
validated instruments wherever possible and translated them into Malayalam. 
Table 4.1 describes question content areas, items completed by research staff 
(sections A, D, and E), and items completed by the patient (sections B and 
C). Section A collected data about medicine use, section D covered patient 
demographics, and section E was used to collect medical chart information 
such as coexisting conditions. Section B included several scales: the 8-item 
Figure 4.2  Meducation study visits, data collected at each visit, and 
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Morisky scale* to measure self-reported medication adherence,27-29 the 
Treatment Satisfaction Questionnaire for Medication to measure medication 
use experience,30 the Michigan Diabetes Knowledge Test to measure patient 
understanding,29 and the Summary of Diabetes Self-Care Activities scale to 
measure self-management activities.26 We developed the Section C items to 
measure patients’ experiences using the Meducation handouts.
The research team obtained qualitative information concerning 
implementation of Meducation and its use once during each data collection 
period through a facilitated staff group discussion. We entered all questionnaire 
and abstracted chart information into a secure web-based database, Epidata,32 
that the MTH uses for research. Data collection and storage was maintained 
securely and in accordance with IRB-approved protocols at MTH and RTI.
Table 4.1  Questionnaire content areas
Questionnaire sections Description
A. Medicine list Medicines used for diabetes, and other medicines
B. Managing diabetes
Diabetes knowledge Nutritional knowledge regarding carbohydrates, oils, 
cereals, and dietary habits; HbA1c; exercise; blood sugar 
testing; care of feet; diabetes complications (Diabetes 
Knowledge Test)25 
Diabetes self-care Self-care activities practiced during the past 7 days 
including nutrition, exercise, testing, checking feet, 
smoking26
Medication adherence Morisky Medication Adherence Scale (MMAS-8)* plus 
reasons for missed doses27-29
Satisfaction with 
medicines
Treatment Satisfaction Questionnaire for Medication30
Social and personal 
impact of diabetes
Questions from the Diabetes Care Profile about functional 
limitations due to diabetes; perceptions of efficacy in self-
managing diabetes31
C. Questions about 
medicine handouts
Questions about the experience using Meducation 
handouts
D. Personal and household 
characteristics
Demographics; other household information such as years 
of education, marital status, worked in the past 7 days
E. Patient chart 
information
Patient height, weight, last HbA1c, prescribed medicines, 
medical conditions
*  Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license 
agreement is available from Donald E. Morisky, ScD, ScM, MSPH, 294 Lindura Court, Las 
Vegas, NV 89138-4632; dmorisky@gmail.com.
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Analysis
We used a mixed-methods approach to analyze the data collected. The 
primary emphasis was to understand the feasibility of implementing and 
using the Meducation system. In addition, as a secondary analysis, we checked 
for the impact of Meducation on patients over time by comparing HbA1c 
and survey responses at baseline with those obtained at 3 months; we also 
compared information from the patient group receiving Meducation with 
information from the comparison group. Specifically, we looked at differences 
in questionnaire scores for medication adherence, diabetes knowledge, 
diabetes self-care, and glycemic control (HbA1c) over time. We also examined 
data from the intervention and the comparison groups to look for differences 
associated with the use of the Meducation handouts. To compare measures 
between groups and within groups, we used a t-test for continuous data or a 
chi-squared test for discrete data.
Results
Participants
A total of 130 individuals consented to participate in the study; we assigned 
65 to the Meducation group and 65 to the comparison group. As Table 4.2 
shows, we saw no statistically significant differences at baseline between groups 








Female (%) 50.8 52.3 51.5
Mean age (years) 53.9 55.0 54.4
Mean time since diagnosis (years) 9.6 9.6 9.6
BMI overall (kg/m2) 26.0 25.3 25.7
Education (years) 12.2 12.0 12.1
Married (%) 88 94 91
Worked in past 7 days (%) 29 35 32
Has health insurance (%) 40 22* 31
Access to the internet (%) 23 26 25
HbA1c (mg/dl) 10.0 9.6 9.8
BMI = body mass index. 
* Difference was significant at p = .02.
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in sex, age, marital status, employment, or access to the internet. However, 
fewer Meducation group participants than comparison group patients had 
health insurance. Participants had an average of 10 years’ duration of diabetes; 
12 years of education; a body mass index of 25.7 (normal is less than 25); and 
an HbA1c of 9.8 (normal is less than 7.0).
Changes Over Time in the Meducation Group
We compared measurements obtained at baseline and those obtained after 
3 months for the participants in the Meducation group.
Diabetes Awareness, Knowledge, and Behavior
Table 4.3 shows the average values among participants using Meducation for 
numerous measures taken at baseline and after 3 months. Each area improved 
except for one measure—overall satisfaction with diabetes medications—
which grew worse. Although 83 percent of participants perceived diabetes self-
Table 4.3  Changes over time in diabetes survey items and HbA1c for Meducation 
participants seen at baseline and 3 months later (up to 42 participants)
Survey items and laboratory test Baseline 3 months Change Significance
Diabetes self-care (% somewhat or 
extremely important)
83 96 Improved
p < .001 
(n = 42)
Diabetes Knowledge Test (score 
out of 13)
7.6 10.2 Improved
p < .001 
(n = 42)
Summary of Diabetes Self-Care 
Activities score (7 days)
2.9 3.4 Improved
p < .001 
(n = 42)
Satisfaction with diabetes 
medicines (% very dissatisfied)
28 69 Worsened
p < .001 
(n = 36)
Side effects for diabetes 
medications (% yes)
34 6 Improved
p < .001 
(n = 35)
Reported missed medication 
doses in the last week (%)
29 29 No change
ns 
(n = 38) 
Morisky Medication Adherence 
Scale (MMAS-8)* (high or  
medium, %)
39 53 Improved
p < .23 
(n = 38)
HbA1c (mg/dl) (laboratory test)
9.6 8.3 Improved
p < .01 
(n = 42)
ns = not significant.
*  Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license 
agreement is available from Donald E. Morisky, ScD, ScM, MSPH, 294 Lindura Court, Las Vegas, NV 
89138-4632; dmorisky@gmail.com.
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care to be important at baseline, they scored, on average, 7.6 out of 13 possible 
points on the Diabetes Knowledge Test and reported engaging in daily self-
management behaviors 2.9 days per week (41 percent of 7 days) at baseline, 
which rose to 3.4 days per week (48 percent) at 3 months.
Diabetes Medicines Over Time
Participants in the Meducation group reported dissatisfaction with their 
diabetes medicines (Table 4.3). At baseline, 28 percent were “very dissatisfied,” 
and this value had worsened significantly at 3 months. Other measures 
improved significantly (side effects) or did not change (missing a medication 
dose in the previous week) over time. Using the 8-item Morisky Medication 
Adherence Scale (MMAS-8), 39 percent showed high or medium adherence; 
the remainder (61 percent) reported low adherence. The MMAS-8 includes 
general questions about medicine use over a longer time horizon.
HbA1c Testing Over Time
Among Meducation participants (Table 4.3), blood testing for HbA1c showed 
significant hyperglycemia (9.6 mg/dl) at baseline. These values improved 
significantly (8.3 mg/dl) at 3 months. 
Experience Using the Meducation Tool
Among participants who responded to survey questions about their use of the 
Meducation tool after 3 months (N ranging from 38 to 41 individuals), more 
than 90 percent reported easily reading the text, finding it to be informative, 
being willing to recommend it to a friend, and wanting information for 
nondiabetes medicines being taken (Table 4.4). Online access issues were 
endorsed much less frequently, however. Most individuals reported wanting to 
receive the Meducation information from the physician (60 percent), versus a 
computer (23 percent) or a pharmacist (13 percent) in the doctor’s office.
Staff Experience
During this study, we conducted informal interviews with MTH staff to 
learn about their experience using Meducation handouts with patients. They 
appreciated having the Meducation printouts for the patients and wanted to 
continue distributing them after the study’s conclusion.
MTH staff found that the process of producing the handouts, which 
required several steps to select prescribing details for each medicine and 
print the handout, took 3 to 4 minutes when the internet was functioning 
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well. When the internet was slow, this step took much longer and led to 
workarounds such as the use of backup electronic documents (PDFs) or 
preprinted documents that provided basic information but were not tailored to 
the individual patient’s medicine dose or schedule. Internet slowing occurred 
almost every day, although full power outages happened less frequently.
Meducation Group vs. Comparison Group: Survey Results and HbA1c Testing
Overall, survey responses in the Meducation and comparison groups were 
similar. We did not observe any significant group differences at baseline or at 
3 months on several data collection instruments. These included the diabetes 
knowledge test (DKT); the Summary of Diabetes Self-Care Activities; and 
the MMAS-8. HbA1c at baseline and at 3 months also did not differ between 
groups.
Table 4.4  Participant responses to a survey at 3 months about use of Meducation
Survey items and Meducation use N
Results  
(3 months)
Read the Meducation handout 41 98%
Could easily read the text 39 100%
Found it useful, helpful, informative 40 93%
Would recommend to a friend or family member 40 93%
Would like handouts for nondiabetes medicines they take 39 93%
Would be able to access online 40 23%
Would be likely to access online, download, and print 40 15%
Would like to view video for complex medicines* 38 69%
What would you MOST prefer?
• Printouts from physician 40 60%
• Computer at doctor’s office 40 23%
• Printouts from pharmacist 40 13%
* Complex medicine example: metered dose inhaler that requires training.
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Discussion
Major Findings and Implications
Our study of the feasibility of providing medication handouts to patients with 
diabetes using internet-based technology in an outpatient clinic in India led to 
several insights and lessons learned. Overall, technical systems worked well. 
Patients appreciated receiving the medication handouts. Staff wished to expand 
use of the system to more patients and to nondiabetes medications such as 
antihypertensives and others that are commonly prescribed.
Given the enthusiastic patient responses, the design, content, organization, 
and language (Malayalam) of the Meducation handouts apparently worked 
well for patients and also pleased the clinic staff. Patients preferred to receive 
information about medications from their doctor (top choice) or from the 
pharmacist (second choice), suggesting that the patients did not want only 
the information. Rather, they wanted the information and an opportunity to 
discuss it with an expert.
Patients reported a high level of schooling—completion of 12th grade—
suggesting high literacy (consistent with regional literacy rates in the State 
of Kerala). The ability to read is not the same as health literacy, however, and 
results from study surveys confirmed that knowledge about diabetes showed 
notable gaps. Patients also reported that they had limited access to the internet, 
underscoring the value of traditional methods of learning such as patient 
dialogue with clinicians and staff.
The improvements over time (from visit 1 to visit 3) in patient diabetes 
knowledge, self-management, medication adherence, and glucose control (as 
measured by the HbA1c) were encouraging. This progress was not, however, 
specific to the Meducation handouts or to the participants in the intervention 
group who received them, and there is still room for further improvement 
within the intervention.
Our findings suggested that the handouts were not the most important 
factor influencing diabetes care. Three factors may have contributed to the 
improvements that we observed over time: (1) patients answered the study 
questions, which probably served to educate them about diabetes; (2) patients 
had more time to communicate with staff as they completed their surveys; 
and (3) patients had increased awareness of their glycemic control via routine 
testing for HbA1c. The routine care that the MTH provided for patients with 
diabetes may also have prompted such improvements. Without testing these 
parameters using comparison groups, however, we cannot draw specific 
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conclusions. With an average disease duration of 10 years, patients seen at the 
MTH were not new to diabetes. This factor suggests that tailoring diabetes 
education might be required to serve the needs of individuals who already 
have knowledge in some areas.
Challenges of the Feasibility Study
We encountered some challenges in this pilot project. First, we had difficulty 
using the internet to produce the printouts. Although power and internet 
outages were infrequent (a few per week, on average), internet slowing was 
very common and made the system unresponsive at times. As a workaround, 
staff used either preprinted handouts during power loss or prestored PDF 
copies of handouts during slowing.
Second, staff faced workflow challenges due to the need for additional time 
with each patient to create handouts and to discuss any questions the patient 
might have. During the project debrief, staff felt that relocating the production 
and distribution of the handouts to the pharmacy would be better for patient 
flow and would permit the patients to spend time with the pharmacist rather 
than with clinic staff. Staff had also observed that patients spent a large 
amount of time during the day waiting for appointments with the doctor, the 
nutritionist, and others. Perhaps this time could be used as an opportunity to 
offer different or additional types of information and instruction to patients.
Third, surveyed participants reported only modest personal use of the 
internet. This circumstance may have reflected internet access limitations 
in the semi-rural community surrounding the MTH; urban internet access 
was likely higher. Accessing Meducation handouts online offers participants 
with internet access some additional features of this tool, such as different 
language translations of the same personalized medication instructions. Given 
that citizens of India speak more than 100 different languages, this feature 
allows medical personnel, patients, and family members to reduce errors in 
communication about use of medications.
Fourth, translation from English to Malayalam proceeded smoothly, with 
small exceptions. One phrase describing the risk of mortality associated with 
a medication proved to be more difficult than others. The phrase in English 
suggests a small mortality risk, whereas native speakers found no way to 
express the risk without saying, in effect, “You will die from this medication.” 
Research staff eventually decided to strike out the printed text (using a black 
marker) to avoid misleading the patient.
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This illustrates a broader cultural context that may be challenging for 
research in LMIC countries. The US Food and Drug Administration requires 
the language about medication risk in the United States, but the agency’s 
policies are unconnected to the use of medicines in India. More adaptation, 
including policy work, may be needed if the information about medicines 
developed for culturally different countries (e.g., the United States as 
contrasted with LMIC nations) is used routinely in a different context—here, 
medical care in India.
Future Research
Our findings suggest several areas for future research. First, greater routine 
use of HbA1c testing may provide important feedback to patients, caregivers, 
and clinicians that improves patients’ self-management, glycemic control, and 
motivation. Thus, we suggest that further study is a critical next step to explore 
the impact of expanded use of the HbA1c on patient engagement.
Moreover, most patients in our study must pay out of pocket for routine 
laboratory tests, although a growing number of patients have health 
insurance coverage. The HbA1c in this study was provided at no charge to the 
participants, so everybody received an HbA1c at each study visit. We wonder, 
therefore, whether this suggests that health care systems should provide the 
HbA1c tests free of charge to help their diabetic patients.
Second, community support for patients with diabetes can help patients 
understand how their behavior contributes to improving (or worsening) 
their disease. Incorporating better medication information into community 
education efforts such as KnowDiabetes (http://knowdiabeteskerala.com/) 
could provide tailored medication information for each patient as part of this 
broader effort. Examining the impact of such interventions would be helpful 
for clinicians and policy makers alike.
Third, we propose that the critical role of the clinic or retail pharmacist 
should be examined more thoroughly. The main reason is that patients 
routinely meet with and speak with their pharmacist to obtain and refill 
medicine prescriptions and get testing supplies, even more frequently than 
they interact with the physician, nurse, or diabetes educator. Patients and 
caregivers tapping into pharmacists’ expertise is an important way for 
them to be able to improve their understanding of medicines. Tools such as 
Meducation could have a meaningful role in fostering the contributions that 
pharmacists can make.
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Conclusions
The pilot use of internet-based software (namely, Meducation) to produce 
diabetes medication handouts at the Medical Trust Hospital and Diabetes 
Care Centre in Kulanada, Kerala, India, demonstrated that the technical 
systems worked, staff and patients were satisfied with the handouts and would 
recommend them to others, and clinic staff wished to expand use of the 
handouts. All participants (with or without handouts) showed improvement 
over time in their diabetes knowledge, medication adherence, self-care 
activities, satisfaction with diabetes medications, and measured HbA1c. These 
improvements may have occurred for several reasons: greater attention and 
time staff spent with study patients, increased patient learning or focus on 
self-management behaviors as a byproduct of completing surveys, increased 
awareness and motivation to achieve glycemic control through HbA1c testing, 
or other factors.
Cultural factors appear to play an important role in the participation of 
patients and caregivers in self-management. Growing use of mobile and 
internet-based tools creates opportunities to leverage technologies in diabetes 
care. Expanding the use of health information technologies in resource-limited 
environments such as hospitals, clinics, and community health centers in 
India holds promise, especially as technology adoption accelerates for both 
individual patients and the health care industry broadly.
Key Findings and Lessons Learned
• Providing tailored, internet-based patient medication handouts to patients with 
diabetes in Kerala, India, during their outpatient visit was a feasible intervention.
• Patients and staff were satisfied with the handouts and would recommend them to 
others.
• Improvements in diabetes knowledge, medication adherence, satisfaction with 
diabetes medicines, and measured HbA1c were seen in both patients who received 
the handouts and in those who did not.
• Improvements for those in both the intervention and the comparison groups may 
be explained by measurement of HbA1c for and research staff giving attention to all 
patients in the study.
• Clinic staff identified the potential role of the retail pharmacist in using this 
medication tool with patients, given that pharmacists had a greater number of 
interactions with patients than physicians, nurses, or other staff had.
76  Chapter 4
References
1. Jha AK, Aubert RE, Yao J, et al. Greater adherence to diabetes drugs is 
linked to less hospital use and could save nearly $5 billion annually. Health 
Aff. 2012;31(8):1836-46.
2. Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its 
treatment, and catastrophic medical spending in 35 developing countries. 
Diabetes Care. 2012;35(2):319-26.
3. Ruiz-Moral R. The role of physician–patient communication in 
promoting patient–participatory decision making. Health Expectations. 
2009;13(1):33-44.
4. McGinnis JM, Saunders RS, Olsen L, editors. Patients charting the course: 
citizen engagement in the learning health system: workshop summary. 
Washington, DC: National Academies Press; 2011.
5. Cobden DS, Niessen LW, Barr CE, et al. Relationships among self-
management, patient perceptions of care, and health economic outcomes 
for decision-making and clinical practice in type 2 diabetes. Value Health. 
2010;13(1):138-47.
6. Wagner EH. Chronic disease management: what will it take to improve 
care for chronic illness? Effective Clin Pract. 1998;1(1):2-4.
7. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with 
chronic illness. Milbank Q. 1996;74(4):511-44.
8. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in 
chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 
2001;27(2):63-80.
9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 
2005;353(5):487-97.
10. Ratzan SC. The national health literacy action plan: the time has come for 
action. J Health Commun. 2010;15(6):575-7.
11. Vancheri C. Innovations in health literacy: workshop summary. 
Washington, DC: National Academies Press; 2011.
12. Wallace A. Low health literacy: overview, assessment, and steps 
toward providing high-quality diabetes care. Diabetes Spectrum. 
2010;23(4):220-7.
 Health Literacy Intervention for Diabetes Medication Adherence in India 77
13. Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy 
and health outcomes: an updated systematic review. Ann Intern Med. 
2011;155(2):97.
14. Kim S, Love F, Quistberg DA, et al. Association of health literacy with 
self-management behavior in patients with diabetes. Diabetes Care. 
2004;27(12):2980-2.
15. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication 
adherence in chronic medical conditions: a systematic review. Arch Intern 
Med. 2007;167(6):540-50.
16. Zullig LL, Peterson ED, Bosworth HB. Strategies to overcome medication 
nonadherence—reply. JAMA. 2014;311(16):1693-4.
17. Agency for Healthcare Research and Quality. AHRQ Health literacy 
universal precautions toolkit, 2nd edition. 2016 [cited 2016 Mar 5]; 
Available from: http://www.ahrq.gov/professionals/quality-patient-safety/
quality-resources/tools/literacy-toolkit/index.html
18. Al-Qazaz H, Sulaiman SA, Hassali MA, et al. Diabetes knowledge, 
medication adherence and glycemic control among patients with type 2 
diabetes. Int J Clin Pharm. 2011;33(6):1028-35.
19. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication 
adherence in chronic medical conditions: a systematic review. Arch Intern 
Med. 2007;167(6):540-9.
20. Jog C. Healthcare technology, patient engagement and adherence: systems 
and business opportunity analysis [Thesis report]. Cambridge, MA: MIT 
Press; 2012.
21. Steinhubl SR, Muse ED, Topol EJ. Can mobile health technologies 
transform health care? JAMA. 2013;310(22):2395-6.
22. Liberman A, Buckingham B. Diabetes technology and the human factor. 
Diabetes Technol Ther. 2016;18 Suppl 1:S101-11.
23. Catherine HY, Bahniwal R, Laupacis A, et al. Systematic review and 
evaluation of web-accessible tools for management of diabetes and related 
cardiovascular risk factors by patients and healthcare providers. J Am Med 
Inform Assoc. 2012;19(4):514-22.
24. National Research Council. Health care comes home: the human factors. 
Washington, DC: National Academies Press; 2011.
78  Chapter 4
25. Al-Qazaz H, Hassali M, Shafie A, et al. The 14-item Michigan Diabetes 
Knowledge Test: translation and validation study of the Malaysian version. 
Pract Diabetes Int. 2010;27(6):238-41a.
26. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care 
activities measure: results from 7 studies and a revised scale. Diabetes 
Care. 2000;23(7):943-50.
27. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a 
medication adherence measure in an outpatient setting. J Clin Hypertens 
(Greenwich). 2008;10(5):348-54.
28. Krousel-Wood MA, Islam T, Webber LS, Re RS, Morisky DE, Muntner P. 
New Medication adherence scale versus pharmacy fill rates in seniors with 
hypertension. Am J Manag Care. 2009;15(1):59-66.
29. Morisky DE, DiMatteo MR. Improving the measurement of self-
reported medication nonadherence: final response. J Clin Epidemio. 
2011;64:258-263.
30. Atkinson MJ, Kumar R, Cappelleri JC, et al. Hierarchical construct 
validity of the Treatment Satisfaction Questionnaire for Medication 
(TSQM version II) among outpatient pharmacy consumers. Value Health. 
2005;8:S9-S24.
31. Fitzgerald JT, Davis WK, Connell CM, et al. Development and validation 
of the Diabetes Care Profile. Eval Health Professions. 1996;19(2):208-30.
32. Lauritsen J, Bruus M. EpiData: a comprehensive tool for validated entry 
and documentation of data [computer program]. Odense, Denmark: 
EpiData Association; 2003.
Introduction
Ischemic stroke occurs when the blood supply to the brain is interrupted or 
severely reduced, depriving brain tissue of necessary oxygen and nutrients. 
Within minutes, brain cells begin to die. Stroke is a leading cause of 
hospitalization, long-term disability, and mortality in the United States and 
globally.1,2 It is a preventable and treatable disease. Over the past two decades, 
a growing body of evidence has suggested that more effective primary and 
secondary prevention strategies, better identification of high-risk individuals, 
and effective interventions soon after the onset of symptoms are keys to a 
better patient outcome.3-6
Patient health outcomes after having an ischemic stroke depend in large 
part on how and when treatments are administered. Better patient outcomes 
are often associated with less time between a patient’s arrival to the hospital 
and administration of treatment. Understanding the care processes that 
contribute to a better outcome has improved, and now good evidence supports 
interventions and care processes in stroke rehabilitation.
Get With The Guidelines-Stroke is a US national registry and quality 
improvement program of the American Heart Association/American Stroke 
Association; it is part of the larger Get With The Guidelines (GWTG) program. 
The program supports clinicians’ adherence to evidence-based guidelines 
in their care of patients hospitalized with stroke.7-10 The GWTG-Stroke 
program is used to improve stroke outcomes in the United States in four 
ways: (1) generating knowledge through research based on registry data; 
(2) identifying areas for quality improvement; (3) improving the development 
of measures, guidelines, and implementation strategies to reduce disparities; 
Implementing “Get With The Guidelines” Stroke 
Program to Improve Health Outcomes of Acute 
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and (4) determining the safety and effectiveness of treatments applied in 
practice.7 
More than 40 percent of all patients hospitalized with stroke in the United 
States are indexed in GWTG-Stroke registry. As of 2013, the registry had 
recorded more than 2.5 million patient admissions. Studies have demonstrated 
that all major quality performance measure indicators have improved since 
the implementation of the GWTG-Stroke programs. These efforts may have 
contributed to the continuing declines in stroke mortality in the United 
States.11
Whether GWTG-Stroke can be successful beyond the United States remains 
to be tested. A key determinant that may hamper broad application of GWTG-
Stroke around the world is the diversity of health care systems and economies. 
Although nations that spend substantially less money on health care than the 
US may find applying GWTG-Stroke processes difficult, experience in one 
Brazilian tertiary hospital12 and in 24 Taiwan hospitals13 suggests that GWTG-
Stroke could be workable in nations with lower health care expenditures.
In China, which has a population of 1.4 billion, stroke kills approximately 
1.6 million individuals each year. This represents an annual stroke mortality 
rate of 157 per 100,000, exceeding cancer, respiratory disease, and heart disease 
as the leading cause of mortality and disability in adults.14-19 The rate of stroke 
mortality in China is almost 4 times that in developed countries, possibly 
attributable to the poor acute care management.2 In addition, 2.5 million new 
stroke cases occur each year, and 7.5 million live with some level of disability 
after surviving a stroke. The geographical difference in stroke incidence in 
China is marked; the rate is highest in the Northeast (486 per 100,000) and 
lower in the South (136 per 100,000).
Methods
The objective of this study was to pilot test the feasibility of adapting the 
GWTG-Stroke program data collection and feedback procedures to the 
Chinese health care system to facilitate the quality of care improvement 
effort in one tertiary hospital in Shanghai, China. RTI International provided 
funding for this pilot project. In addition, we received a small grant (100,000 
Chinese Yuan) from the Shanghai Health Bureau to support local staff and data 
system development. The full GWTG-Stroke program includes a structured 
quality improvement program based on the model for improvement, which 
has been implemented in Taiwan and elsewhere. That element of the entire 
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stroke program was, however, beyond the scope of this specific pilot project in 
Shanghai.
This pilot study had four specific aims: 
1. Develop a Chinese version of an electronic data collection tool and 
registry system with the goal of integration with electronic health 
records to support evaluation of care delivery and patient outcomes 
directly.
2. Deploy a registry data system to collect patient and clinical care 
information and data.
3. Use stroke care performance measures and individual-level data to 
evaluate guideline adherence in the hospital.
4. Evaluate the usability and feasibility of such a registry data system for 
improving the quality of care in Chinese health care system.
Project Site
Our chosen pilot site was 1 of the 12 hospitals affiliated with Shanghai Jiao 
Tong University School of Medicine. The hospital is considered among the best 
hospitals in China and has more than 3,200 beds and nearly 5,000 physicians 
and staff. It provides more than 3 million outpatient visits and 10,000 inpatient 
services each year. Its neurology department has 54 physicians specializing 
in various neurological diseases and disorders. The department treats 
approximately 1,200 stroke patients each year.
Project and Research Staff
Project team members at the selected hospital established a registry team 
that included specialists and staff in emergency medicine, neurology (stroke), 
general practitioners, epidemiology, biostatistics, program management and 
coordination, legal/patient privacy, quality of care assurance, information 
technology (IT), and database management. One nurse served as the project 
coordinator; four PhD or MPH students served as research associates or 
assistants for the project.
The executive team, consisting of the coauthors, neurology department 
chief, and section chief, assumed responsibility for the administrative, ethical, 
and scientific decisions that determined the direction of the registry. It made 
decisions with appropriate input from legal, scientific, and administrative 
experts. The scientific committee included experts in various areas including 
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database content, clinical research, and epidemiology and biostatistics. The 
committee determined the scientific aspects of the registry data system, such 
as data elements, direction of database inquiries, and specific analyses. It also 
developed a governance and oversight plan, study policies, a protocol, and an 
operational manual to guide the process of data collection and quality of care 
improvement efforts. Institutional Review Board (IRB) approval was obtained 
from the Shanghai Jiao Tong University School of Medicine.
The scientific committee also put the data elements and definitions, 
patient outcomes, and target population into final form (to fit the specifics 
of the Chinese health care delivery system). Members also identified patient 
characteristics, with input from various stakeholders. We developed a unified 
online data collection interface and registry data system to integrate as much 
as possible with the hospital’s electronic health records and directly support 
evaluation of care delivery and patient outcomes.
Registry Development
VitalStrategic Research Institute (Shanghai, China) provided subcontractor 
assistance to develop the data collection tools and system to support the 
stroke registry. The VitalStrategic Research Platforms have been used in 
several national registries, including the China Cardiometabolic Registries 
(CCMR) and the China Chronic Disease Registries (CCDR). The system 
includes a web-based electronic data capture system, VitalEDC; an electronic 
hospital records link system, VitalConnect; and a data management system, 
VitalManage, as well as a health information system (VitalHIS) and clinical 
information system (VitalCIS) (Figure 5.1).
The stroke registry data elements include the following categories:
• Demographics: age, sex, ethnicity, place of residence, education level, and 
marriage status
• Prehospital or emergency medical services data: arrival mode, time of 
arrival, time seen by physician, transfer, in-hospital stroke, direct admit
• Imaging: date and time, initial findings
• Sign and symptom onset: date and time; National Institutes of Health 
(NIH) Stroke Scale (optional); functional status (optional)
• Thrombolytic therapy: time, complications, reasons for no treatment
• Medical history: stroke or transient ischemic attack, coronary heart 
disease, peripheral vascular disease, atrial fibrillation, hypertension, 
smoking, dyslipidemia, diabetes, and obesity
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• In-hospital diagnostic procedures and treatment: atrial fibrillation, time 
for antithrombotic therapy; deep vein thrombosis prophylaxis; dysphagia 
screening
• Other in-hospital complications: deep vein thrombosis, pneumonia
• Discharge data: date of discharge, International Classification of 
Diseases (ICD)–9 codes, discharge destination, functional status, 
smoking cessation counseling, lipid profile, lipid-lowering medications, 
antithrombotic medication, and reasons for no treatment, if any.
The following quality measures were used as the indicators for the quality of 
stroke care:
• Eligible patients who receive acute thrombolytic therapy
• Patients with atrial fibrillation who receive anticoagulation therapy in 
hospital
• Patients who are evaluated for dysphagia in hospital
• Patients who receive needed antithrombotic, cholesterol lowering, 
antihypertensive, and diabetes medications at discharge
• Smokers who receive advice and assistance in quitting.







Source: VitalsStrategic.com. Used with permission.
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Data Collection
We collected data from consecutive patients before (November to December 
2013) and after (March to July 2014) implementation of the new data system. 
We focused on patients who met one of the predefined case definitions 
for ischemic stroke, transient ischemic attack, intracerebral hemorrhage, 
subarachnoid hemorrhages, and other unspecified types of strokes.
Before implementing the new data system, we used retrospective data 
collection to obtain baseline data. We identified stroke cases based on 
ICD-9 codes 430–436 as primary or secondary discharge diagnoses. Trained 
abstractors conducted chart abstraction based on central or local chart reviews 
(or both). After implementing the new data system, we used a prospective 
approach to enroll the cases through active case surveillance (“hot pursuit”) 
of subjects presenting with stroke-like signs and symptoms to the pilot 
site hospital. Trained clinical coordinators did all the data collection and 
abstractions.
Project staff implemented rigorous quality control and assurance processes 
and a feedback system to ensure the quality of data. Staff were trained to 
adhere to data collection and coding procedures and protocols. Approximately 
10 percent of records were reabstracted to validate the reliability of data.
For this analysis, project staff collected the characteristics of stroke 
patients and series of quality of care performance indicators before and after 
implementation of the stroke registry system. We used simple statistics to 
compare the groups before and after system implementation.
Results
Before implementing the data system, hospital research staff reviewed 
445 consecutive cases of stroke over the 2-month period (November 
and December). Of these, 254 cases (57 percent) were ischemic stroke; 
67 (15 percent) transient ischemic attack; 58 (13 percent) intracerebral 
hemorrhage; 40 (9 percent) subarachnoid hemorrhage; and 39 (6 percent) 
unknown type. After implementing the new system, we reviewed a total of 
878 cases. Of these, 483 (55 percent) were ischemic stroke; 88 (10 percent) 
transient ischemic attack; 132 (15 percent) intracerebral hemorrhage; 
70 (8 percent) subarachnoid hemorrhage; and 105 (12 percent) unknown type.
Table 5.1 shows the characteristics of patients with ischemic stroke before 
and after the implementation of the electronic system. Patient characteristics 
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did not differ significantly before and after implementation of the new system 
The delay in the time from stroke onset to emergency department arrival in 
this patient group (i.e., those with ischemic stroke) was considerable. Only 5 
to 7 percent of patients arrived in the emergency department within 2 hours 
of the stroke onset (Table 5.2). The delay time from stroke onset to emergency 
department arrival did not differ significantly before and after implementation 
of the new system.
Table 5.1  Characteristics of patients with ischemic stroke before and after registry 
implementation
Characteristics Before (N = 254) After (N = 483)
Men (%) 64 62
Age (years, mean ± SD) 68 ± 12 70 ± 13
Married (%) 60 63
Education less than high school (%) 18 21
High blood pressure (%) 70 72
Total cholesterol over 200 mg/dl (%) 35 38
Ever smoking (%) 56 60
Diabetes (%) 20 24
Atrial fibrillation (%) 12 11
SD = standard deviation.
Table 5.2  Time from ischemic stroke onset to arrival in the emergency department 
before and after registry implementation
Time Period Before (%) After (%)
Less than 2 hours 5 7
2–3 hours 4 5
3–6 hours 10 12
More than 6 hours 32 33
Unknown or missing 49 43
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Less than 5 percent of patients received intravenous (IV) tissue plasminogen 
activator (tPA) in this patient group. However, major quality indicators 
improved somewhat after the implementation of the new data system 
(Figure 5.2).
Figure 5.2  Major indicators for stroke care before and after the data 
collection registry implementation













































Improving the quality of stroke prevention and care is a global public 
health priority. Evidence-based therapeutic and preventive measures are 
available for ischemic stroke but remain significantly underused in China. 
GWTG-Stroke, a landmark American Heart Association/American Stroke 
Association initiative, showed substantial and sustained improvements, based 
IV tPA 3 Hr = intravenous tissue plasminogen activator within 3 hours; AT = antithrombotics;  
DVT = deep vein thrombosis; Scr = screening; DC = discharge; AC = anticoagulation therapy;  
AF = atrial fibrillation; lipid = lipid-lowering medications; BP Meds = blood pressure medications;  
SMK Cessat = smoking cessation; DM Meds = diabetes mellitus medications.
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on predefined performance measures, on quality of stroke care and prevention 
in 790 US hospitals.10 Whether GWTG-Stroke is applicable outside the 
United States to benefit nations with different health care infrastructures and 
economies remains to be determined. Our study suggested that applying the 
GWTG-Stroke data collection and feedback procedures is feasible in a country 
that spends substantially less than the US does in health care dollars under a 
public health insurance program.
Patient characteristics, including stroke types and subtypes, and risk factor 
profiles were largely comparable between patients in Shanghai and those in the 
US GWTG-Stroke program. Delays in hospital arrival after the onset of stroke 
were considerable in Shanghai, where only 5 to 7 percent of patients arrived at 
the hospital within 2 hours of the onset of stroke symptoms. Nearly 50 percent 
of patients did not have clear information on either the time of onset of 
symptoms or the time of arrival at the hospital. These data suggest a need for 
increasing the public awareness of stroke signs and symptoms and for a timely 
response to stroke.
Early prescription of antithrombotic medications and prescription of 
antithrombotics on discharge both occurred at a lower rate for Shanghai 
patients compared with the rates for US patients. This could be attributed 
partly to local practice, which does not favor aggressive stroke prevention in 
patients with poor functional outcomes. This gap suggests that more rigorous 
adherence to this GWTG-Stroke guideline is needed, including aggressive 
treatment for those with poor functional outcomes, especially when more 
favorable outcomes were noted among patients who received antithrombotics 
on discharge than among those who did not.
The other performance measures show substantial disparity between this 
study and GWTG-Stroke. The most striking difference was use of IV tPA for 
those arriving within 3 hours of stroke onset: 4 percent in Shanghai versus 
73 percent in GWTG-Stroke.9 Shanghai data also showed that only 2 percent 
of patients with ischemic stroke received IV tPA treatment. IV tPA is an 
important measure of the quality of stroke care and reflects the readiness 
of a stroke center to treat patients with stroke in an emergency setting with 
adequate facilities, staffing, and training. The relatively late arrival of patients 
with stroke is a likely cause of the low IV tPA rate. Only 5 to 7 percent of 
Shanghai patients with ischemic stroke arrived within 2 hours of stroke onset 
and in time for IV tPA treatment. 
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Shanghai needs more public education and more rigorous community 
outreach programs. Together, these findings suggest that stroke centers in 
Shanghai are far behind in fulfilling an important therapeutic measure in acute 
stroke care. This was especially the case when patients with ischemic stroke 
who arrived within 2 hours and received tPA experienced better functional 
outcomes compared with those who also arrived within 2 hours and did not 
receive tPA.
Anticoagulant treatment for patients with atrial fibrillation; prescription of 
medications for hyperlipidemia, hypertension, and diabetes; and counseling 
for smoking cessation were all given at a substantially lower rate for Shanghai 
patients than for US patients in the GWTG-Stroke program. This finding 
indicates that important preventive measures also need to be improved greatly 
in Shanghai.
After the implementation of the registry system, all quality-of-care 
indicators improved somewhat. This could be attributed mainly to the 
attention to care from physicians and nurses. This finding suggests that 
implementing such a program may indeed help improve the quality of care. 
Nevertheless, data collection and feedback are insufficient to achieve high 
levels of performance. Major barriers to data collection include difficulties 
in automating interfaces with the laboratory, imaging, and hospital health 
information systems. Thus, more manual data entry was required than 
anticipated because of increased resource requirements. In addition, barriers 
to interfacing with prehospital or emergency medical service systems impeded 
efforts to reduce prehospital delays in stroke treatment. Inconsistencies in data 
definitions and systems among hospitals will likely be a potential barrier to 
expansion of the registry to additional hospitals, and any future projects will 
need to address these issues at the outset.
In conclusion, implementing a registry system in Shanghai to support the 
Get With The Guidelines program to improve the quality of stroke care is 
feasible. This element of the larger program is critical to support a team-based 
quality improvement program in China with the expectation of improving 
stroke care quality and stroke outcomes. Also, public health interventions to 
raise awareness of the signs and symptoms of stroke, complemented by active 
improvement and integration of the components of systems of stroke care, are 
necessary to improve stroke outcomes in China.
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Key Findings and Lessons Learned
• The delay in the time from the onset of ischemic stroke to arrival at the emergency 
department in Shanghai was considerable. The proportions of eligible ischemic 
stroke patients treated with tPA and given prescriptions for therapies for 
preventable conditions were considerably lower than in the West.
• After implementation of the new data system, major quality indicators improved.
• Implementation of a “Get With The Guidelines” program to improve the quality of 
stroke care is feasible, but considerable difficulties exist. These specifically involve 
hospital internal policies, conflict between the hospital information system and the 
registry data system, impossibility of automated data upload, and inconsistencies in 
data definitions and systems among hospitals.
• Public health interventions to raise the awareness of the signs and symptoms 
of stroke and to decrease the delay in seeking care, complemented by active 
improvement and integration of the components of systems of stroke care, are 
critical to raising survival rates from stroke in Shanghai.
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Encouraging Primary Care Physicians to Talk  
With Their Patients About Stroke Risk Factors:  
A Brief Intervention in Indonesia
Pamela A. Williams and Kenneth A. LaBresh
Introduction
In Indonesia and other low- and middle-income countries (LMICs) around the 
globe, stroke presents a huge burden of death, disability, and health care costs. 
Ischemic heart disease, cerebrovascular disease, and stroke together are the 
leading contributors to this global burden of death and disability.1 Mortality 
rates from stroke are greater in LMICs than in high-income countries.2 Stroke 
is the leading cause of death in Indonesia,3 accounting for approximately 
15 percent of all deaths.4
Failure to assess and reduce the risk of stroke in patients seen in primary 
care practices is one reason for the greater stroke burden in LMICs than in 
high-income countries.2 The Ministry of Health of Indonesia emphasized that 
community education is instrumental in addressing the increase in stroke 
and other noncommunicable diseases (NCDs) in its Strategic Plan.5 The 
Indonesian Neurological Association has established guidelines for stroke 
care across the care continuum from prevention to rehabilitation of stroke 
patients6; however, Indonesia has not established required stroke risk screening 
programs for primary care physicians to implement.
The leading modifiable risk factors for stroke are unhealthy diet, physical 
inactivity, smoking tobacco, hypertension, and overweight or obesity; 
collectively, these contribute 80 percent of stroke risk.2 Not surprisingly, the 
prevalence of these risk factors is high in Indonesia. Percentages of Indonesians 
with such risk factors are as follows: low-fiber diet (94 percent), physical 
inactivity (42 percent), smoking (29 percent), hypertension (27 percent), and 
obesity (15 percent).7
Advice for patients on modifiable risk factors and improved screening 
practices, along with policy changes, are critical to lessen stroke burden in 
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Indonesia.8,9 In LMICs such as Indonesia, interventions that work within the 
primary health care system may provide optimal benefit and convenience.8 
However, little is known about the stroke risk screening practices of primary 
care physicians in Indonesia and how they talk with patients about addressing 
their stroke risk factors through behavior changes.
This pilot project had two main objectives. The first was to learn about the 
current practices of primary care physicians in Indonesia and devise strategies 
to motivate them to screen patients and inform them about their stroke 
risk factors. The second was to test the impact of a brief intervention on the 
frequency with which physicians screen their patients to assess their risk for 
stroke and recommend risk-factor modifications.
Methods
Collaborators and Sites
We collaborated with in-country researchers from the School of Medicine at 
Gadjah Mada University (UGM) for all phases of the research. For the setting, 
we focused on puskesmas, free primary health care clinics located within each 
health district in Indonesia. Puskesmas, as the primary health facilities in the 
country’s National Health Insurance program, provide comprehensive health 
services, including promotion, preventive, treatment, rehabilitation, obstetric, 
and medical emergency services. They are the first level of health service that 
patients seek for health care.10 We selected Yogyakarta City as our primary site 
because it has the second-highest diagnosed stroke prevalence in Indonesia 
(10.3 per million).11
Study Phases
The study was carried out from July 2013 to April 2014. We first conducted 
focus groups with primary care physicians representing puskesmas in 
Yogyakarta City to gain a better understanding of their current stroke risk 
screening practices and to learn about the context to facilitate development of 
the intervention.12 Then, based in part on these formative data, we developed 
the intervention and measured its impact on physicians’ discussions with 
patients about their stroke risk and recommendations to modify their risk 
factors. Finally, we conducted limited in-depth interviews with the primary 
care physicians and nurses who conducted the intervention at the puskesmas to 
learn how to improve the intervention for the future.13
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Focus Groups
We conducted three focus groups with a convenience sample of 23 physicians 
in Yogyakarta City, Indonesia, who work in puskesmas. The physicians who 
participated were mostly female (60 percent), with an average age of 33 
years. They had been practicing medicine for an average of 7 years. Nearly 
three-quarters of them had not had formal stroke prevention training. Many 
also worked in private practice, other public clinics, or hospitals.
Intervention Study
We employed a quasi-experimental design, as the resources were not available 
to support random assignment of a sufficient number of clinics to treatment or 
comparison conditions to have adequate power to detect any treatment effects. 
Specifically, we selected an interrupted time-series design, involving multiple 
pretest and posttest observations at equal intervals of time over a 15-week 
period across four puskesmas.14 Each puskesmas received the intervention, but 
the timing of the start of the intervention and the number of data collection 
intervals varied over the 15-week period. We distributed the intervention 
materials for 8 weeks at each of the four puskesmas.
During the intervention, nurses placed a checklist of modifiable stroke risk 
factors (i.e., blood pressure, smoking, diet, body weight, physical activity) in 
physicians’ charts for them to discuss with their patients. Nurses also gave 
patients a one-page educational worksheet covering the same list of stroke 
risk factors to complete in the waiting room before their appointment with 
the physician. During both intervention and nonintervention assessment 
weeks, trained interviewers conducted exit interviews with a total of 675 
adult patients with no history of stroke immediately following their medical 
appointments to assess whether their physicians discussed with them their 
stroke risk factors and recommended behavior changes.
In-depth Interviews
We recruited a convenience sample of eight physicians and nurses who had 
administered the intervention (two per puskesmas) for one-on-one in-depth 
interviews to learn about their experiences with the intervention.
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Results
Focus Groups
Findings from the focus groups provided important context for developing the 
intervention. Physician procedures for screening patients for stroke risk factors 
varied considerably. Physicians reported that they screened patients depending 
on patient appearance (e.g., yellowed teeth from smoking cigarettes), 
complaints, or the presence of other related risk factors (e.g., diabetes), rather 
than on risk for future events. Typically, healthy patients are not screened for 
modifiable risk factors.
The top barrier to physicians screening for stroke risk was lack of time 
during appointments. Each puskesmas is staffed with three or four physicians 
who treat 80 to 150 patients within a 4-hour period, often meaning 5 to 
10 minutes for the average physician consultation. Furthermore, care in 
the puskesmas is structured so that a patient does not always see the same 
physician, which makes it challenging to monitor a patient’s behaviors over 
time. Patients’ limited education and physicians’ beliefs that patients are 
reluctant to change their habits are also important obstacles.
Given these barriers, physicians said that the most appealing intervention 
approaches for them were those that were brief and easy to use, such as simple 
checklists. For patients, they recommended using stroke prevention education 
materials such as simple leaflets with common language and pictures or 
visuals, among other options.12
Intervention Study
The intervention did not increase the likelihood that physicians would discuss 
patients’ risks for stroke in general. That is, it did not increase whether patients 
reported that the physician discussed their blood pressure, smoking status, 
fruit and vegetable intake, physical activity, or body weight (or some mix of 
these topics). It did, however, increase the likelihood that physicians would 
recommend that patients change their modifiable stroke risks. For example, 
patients affirmed that the physician recommended that they should lower 
their blood pressure. Physicians more frequently recommended that patients 
lower their blood pressure and get physical activity than they addressed other 
modifiable risk factors.
Based on data that patients reported in exit interviews, physicians 
are holding discussions with patients about their stroke risk factors less 
than half of the time (other than discussing their blood pressure levels). 
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Moreover, recommendations on modifying their stroke risk factors occur 
even less frequently. Williams and colleagues provide a full description of the 
intervention study methods and findings.13
In-depth Interviews
Nurses and physicians who implemented the intervention and participated 
in the interviews cited barriers to implementation. These obstacles included 
competing priorities, such as addressing health problems from volcanic ash. 
Such responsibilities increased their workload for only a few days, but the need 
to juggle these concerns serves as a reminder that volcanic eruptions and other 
environmental events are frequent in this part of Indonesia. Overcrowded 
facilities were another problem. For instance, in two of the four puskesmas, the 
physician and nurse were located in the same examination room because of the 
limited space. Poor motivation and lack of buy-in from physicians and nurses 
were yet other barriers.
Respondents reported that having limited numbers of staff was a challenge. 
For that reason, they focused on assessing risk only for patients perceived 
as having a very high risk for stroke, instead of for all patients (primary 
prevention) as the intervention had intended. They also reported that 
physicians and nurses were initially enthusiastic about implementing the 
intervention. Because health care is free at puskesmas, however, many patients 
come for care frequently. The arrival of repeat patients lessened the physicians’ 
and nurses’  motivation to repeat the intervention with these patients.
The interviewees made suggestions for future similar studies. One was 
to provide individual nurses and physicians with incentives (e.g., money), 
particularly incentives based on the number of patients served, to encourage 
them to implement the intervention. This study provided monetary incentives 
to each puskesmas only to offset time for participation in the study. Another 
was to have an assistant at each puskesmas to help patients complete the patient 
educational worksheet (e.g., elderly patients need assistance if they do not have 
their glasses). They also recommended that one physician at each puskesmas 
coordinate the study.
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Discussion
Failure to screen patients in primary care and thereby reduce stroke risk is one 
reason for the disproportionate stroke burden in LMICs such as Indonesia.2 
Thus, improving the regularity of these practices is particularly important. 
Other experts have suggested that primary prevention interventions that use 
a comprehensive approach for improving common risk factors for NCDs via 
population-based approaches are the most cost-effective means for slowing 
their worsening.8,9 Given that stroke is the leading cause of death in Indonesia, 
which is the fourth most populous country in the world, interventions to 
improve screening and reduce risk hold considerable promise for reducing the 
burden of stroke and cardiovascular disease in this very large LMIC.3,15
This study gathered important contextual information on the current 
stroke screening practices of primary care physicians who work in puskesmas 
in Yogyakarta City, Indonesia, and on the organizational environment of 
the puskesmas. We found that a brief intervention to motivate puskesmas’ 
physicians raised the likelihood that they would recommend that patients 
change their modifiable stroke risks. However, getting primary care physicians 
and nurses at puskesmas to conduct even a brief intervention consistently was 
difficult, although they had been trained on the brief intervention. Physicians 
often did not routinely discuss and make recommendations on modifying 
patient stroke risk factors, as we had envisioned.
This outcome was not entirely surprising, because successful 
implementation of interventions often requires synergy among patients, 
physicians, and organizations.16 Indonesia does not have established stroke 
risk screening programs that give priority to conducting primary stroke 
prevention in primary care facilities. The intervention that we put in place 
represented a significant change from the usual care delivered by puskesmas’ 
physicians, despite our efforts to make it brief. Further organizational barriers 
included lack of time, resources, and established systems for stroke risk 
assessment, using the resources available in the puskesmas.
Physician and nurse attitudes, including lack of motivation and the inertia 
of usual care routines, also played a role. During focus groups, physicians often 
reported that patients were “stubborn” about modifying their risk behaviors. 
This indicated that physicians may believe that talking with patients about 
their risk factors will not change patient behaviors. It may also reflect that 
physicians do not feel confident in their skills to discuss behavior change 
with patients.17,18 These knowledge, organizational, and attitudinal barriers 
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are common barriers to physician adherence to practice guidelines related to 
behavior change.18,19
Future implementations of the intervention should address these barriers. 
First, training for physicians, such as motivational interviewing, could support 
them in overcoming knowledge barriers. Second, nurses and physicians who 
carried out the intervention suggested that providing incentives (e.g., money) 
for physicians and nurses, particularly based on the number of patients served, 
could tackle some of the attitudinal barriers. This study provided incentives 
to each puskesmas only to offset time for research participation. Certainly, 
offering reimbursement or other incentives is an organizational strategy that 
can address these types of barriers.16 Third, providing educational materials 
that physicians can give patients, establishing champions at each puskesmas 
who serve as role models for physicians, and shifting some physician 
responsibilities to other staff may help overcome some of the organizational 
barriers to delivering primary prevention stroke screening services. Fourth, 
identifying risk factors before a primary care visit could reduce the burden that 
puskesmas physicians face both to screen patients and to provide treatment 
and recommendations to reduce their risk. Finally, implementing programs to 
redesign clinical workflows and better use ancillary staff may help physicians 
to focus on providing specific recommendations and motivation for patients to 
change behaviors associated with increased risk for stroke.20
Through this pilot study, we gained insight into the way the Indonesian 
health system functions and a better sense of the feasibility of interventions 
within the system. Despite partnering with an in-country collaborator and 
conducting formative focus groups with physicians in puskesmas before 
developing and implementing the intervention, we learned additional lessons 
through implementing the intervention study and conducting follow-up 
interviews. The latter, in particular, were an important source of information 
about the medical practice environment, which in turn could be used to design 
more comprehensive and larger-scale interventions.
A larger follow-up study could address many of the barriers we identified. 
These especially include finding ways to provide physicians with more 
organizational supports. Such assistance permits clinicians to spend more time 
with patients and fosters greater accountability for preventive practices, such as 
occurs now in private practice clinics. Conducting such a study in a different 
health care setting in Indonesia would allow researchers to isolate the role 
of the systemic differences between two delivery models (puskesmas versus 
private practice) and could help ascertain what changes are possible.
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Based on this pilot work, potential next steps include conducting a similar 
intervention in a setting in which physicians have more environmental and 
system supports, such as those that exist in private practice clinics. Addressing 
these larger environmental and organizational barriers is important as part 
of a more comprehensive project that could address stroke risk screening and 
targeted interventions to modify stroke risk factors in health care settings in 
Indonesia. Such a project has the potential to reduce future disease burden for 
stroke and other cardiovascular diseases.
The findings from this project reinforce the concept that the barriers in 
one setting may not generalize to another setting without modifications 
to address them.18 This is especially true when embarking on a study in a 
country with a different health care system and its own unique challenges. 
Nonetheless, for stroke prevention in particular and prevention of NCDs in 
general, overcoming these barriers is crucial. In the current context of global 
health, stroke cannot be considered in isolation; rather it should be seen as 
a major component of prominent NCDs including cerebrovascular diseases, 
cancers, chronic respiratory diseases, and diabetes mellitus.1 In Indonesia, the 
prevalence of the leading modifiable risk factors for stroke is high, including 
hypertension, smoking tobacco, overweight or obesity, unhealthy diet, and 
physical inactivity7; these are also risk factors for other leading NCDs. The 
United Nations declaration to reduce premature death attributable to NCDs 
by 25 percent by 2025 included targets of relative reductions in each of the 
behaviors targeted in this intervention for stroke prevention.21 These behaviors 
are important for NCD prevention in general.
Conclusion
With this pilot project, we aimed to learn the current stroke screening 
practices of primary care physicians who work in puskesmas in Indonesia. 
We wanted insight into intervention strategies that we could use to motivate 
physicians to talk with their patients about stroke risk factors. We developed 
and tested the feasibility and impact of implementing a brief intervention 
in puskesmas. Finally, we asked for feedback from physicians and nurses 
who implemented the intervention to improve future implementation of the 
intervention.
We learned that physicians do not routinely screen patients on their stroke 
risk factors. Limited time with patients and the belief that patients often do 
not change their risk behaviors were key barriers to doing so. We found that a 
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brief intervention in puskesmas, consisting of a checklist of modifiable stroke 
risk factors for physicians and a patient education worksheet on the same risk 
factors, can increase the likelihood of physicians’ recommending that patients 
change their modifiable stroke risks. Nevertheless, physicians often did not 
routinely discuss and make recommendations for modifying patient stroke risk 
factors, as we had envisioned.
The intervention may need to develop support for physicians—such as 
medical training, educational materials for patients, champions who serve 
as role models, and health care system supports that shift some of their 
responsibilities to other staff. In these ways, programs can realize their full 
potential and address the barriers to intervention implementation that this 
study identified.
Key Findings and Lessons Learned
• Primary care physicians in puskesmas in Indonesia do not routinely screen 
patients on their modifiable stroke risk factors (primary prevention).
• A brief intervention conducted in puskesmas increased the likelihood of 
physicians’ recommending that patients change their modifiable stroke risks 
(lower blood pressure, eat more fruits and vegetables, get exercise, and lose 
weight).
• Physicians and nurses did not consistently implement the intervention during 
the study. 
• Addressing barriers to implementing the intervention, particularly related 
to physicians’ knowledge and attitudes and to the health care organization, 
is crucial to improve the consistency of implementation and (likely) the 
intervention’s impact.
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Deciphering Chronic Kidney Disease of  
Unknown Etiology in Sri Lanka
Jennifer Hoponick Redmon, Myles F. Elledge,  
Kamani P. Wanigasuriya, Rajitha Wickremasinghe,  
and Keith E. Levine
Introduction and Background
Geographic Setting
Sri Lanka is an ethnically, culturally, and geographically diverse island nation 
located in the northern Indian Ocean off the coast of India. Although the 
country has many urban areas, the vast majority of its 20 million people reside 
in rural settings. Sri Lanka has recently transitioned from a low- to a middle-
income nation and is undergoing a significant demographic shift. It has a large 
young population, but it also has one of the largest elderly populations in the 
developing world. The average life expectancy is now greater than 75 years 
and rising.
Sri Lanka maintains one of the strongest public health systems in 
developing Asia. The system is built on a foundation of community-based 
medical doctors, a network of mobile midwives and environmental health 
officers, and a commitment to investing in public health research and training. 
Similar to other recently established middle-income countries, the disease 
pattern has shifted away from infectious, maternal, and childhood concerns 
toward noncommunicable diseases (NCDs).
Noncommunicable Disease Burden
NCDs currently account for nearly 90 percent of the overall disease burden 
in Sri Lanka.1 An increasing proportion of the Sri Lankan population is 
affected by NCDs attributable to several suspected factors; these include a 
rapidly changing age distribution, economic development, urbanization, 
reduced levels of physical activity, a decline in healthy eating patterns, and 
tobacco, alcohol, and substance use and abuse. NCDs are often perceived 
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to be associated with affluent lifestyles, but they are also a burden for more 
impoverished areas of Sri Lanka. The prevalence of hypertension, for example, 
does not show a significant difference between the lowest and highest wealth 
groups.
The Chronic Kidney Disease of Unknown Etiology Epidemic
A rapidly growing facet of the NCD disease burden is chronic kidney disease 
(CKD). What is particularly perplexing is that CKD of unknown etiology 
(CKDu) is causing a public health epidemic in Sri Lanka and other developing 
countries with rural agriculture. These cases are concentrated in the North 
Central Province but are found throughout Sri Lanka’s dry zone, which gets 
approximately 3.6 to 50 mm of precipitation annually (Figure 7.1). 
Figure 7.1  Provinces in the dry zones of Sri Lanka are affected by chronic 
kidney disease of unknown etiology
 
 






















Sources: Dry zone data - University 
of East Anglia Climatic Research Unit 
(July 2009); endemic provinces - 
Redmon et al., 2014.
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Since the early 1990s, the number of CKDu cases has risen appreciably; 
about 2,000 new patients seek treatment annually in Sri Lanka. Overall, 
approximately 20,000 to 22,000 individuals are affected. Approximately 
8,000 CKDu patients are under treatment in endemic areas.2,3 
Diagnosing CKDu
Patients diagnosed with CKDu have CKD with a typical HbA1C below 
6.5 percent (not diabetic), blood pressure below 160/100 mm Hg untreated 
or below140/90 mm Hg on up to two antihypertensive medications (not 
hypertensive), and no history of snake bite or other known risk factors 
associated with traditional CKD.4 The consensus is that CKDu in Sri Lanka 
is asymptomatic in early stages but slowly progresses until late stages, when 
symptoms appear and the disease is characterized by renal tubular and 
interstitial damage. CKDu is present among both sexes, but more patients are 
men (especially those aged 30 to 60 years), the majority of late-stage cases are 
observed in men, and men appear to have the most severe cases.5-7
Searching for CKDu Risk Factors
The causes of CKDu genesis and progression are likely multifaceted. Potential 
risk factors hypothesized or reported include environmental exposure to 
nephrotoxins, agricultural work, diet and nutrition, dehydration, lifestyle 
factors, and genetic susceptibility.8,9 The disease is slowly progressive and takes 
many years for symptoms such as fatigue, panting, nausea, anemia, and severe 
pain to develop. Upon diagnosis, the impact is traumatic for patients and their 
families, who are often unable to pay the high direct and indirect costs of the 
renal dialysis treatments necessary to prolong life.10
Within endemic areas, CKDu has affected primarily people of lower 
socioeconomic status who reside in agricultural areas or engage directly in 
farming. The World Health Organization (WHO) estimates that 15 percent 
of the region’s population of 2.5 million is at risk. CKDu is requiring an 
increasingly larger proportion of limited health care budgets, and the 
potential risk factors associated with it are not yet understood well enough for 
educational awareness and prevention efforts to be effective.2,3 Furthermore, 
the number of individuals with CKDu is likely underreported because of the 
lack of symptoms prior to advanced stages, the high costs associated with 
medical care, and the limited number of dialysis clinics.
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CKDu Hot Spots Around the Globe
Geographical hot spots of CKDu have emerged in numerous countries 
spanning the globe. Rural inhabitants of Central America, including those in 
localized geographical areas within El Salvador, Nicaragua, and Mexico, have 
experienced a rapidly expanding CKDu epidemic since 2000.11-14 CKDu in 
Central America is prevalent among young male agricultural workers engaged 
in sugarcane or cotton farming under very hot conditions. Patients experience 
a progressive, asymptomatic decline in kidney function, as measured by 
estimated glomerular filtration rate (eGFR).15-18 Other important hot spots 
include India, where the disease pattern appears similar to that observed in 
Central America, and Tunisia, Serbia, Bulgaria, Croatia, and other localized 
areas within the Balkan Peninsula, where thousands of people have been 
affected.19-22
Project Collaboration Background
The size and scope of this emerging Sri Lankan health crisis prompted 
Professor Ananda Rajitha Wickremasinghe from the University of Kelaniya’s 
Department of Public Health to initiate contact with RTI and formally ask 
whether RTI’s advanced analytical skills and instrumentation could be used 
to obtain laboratory analytical results for biological and environmental 
samples that had already been collected in selected CKDu-endemic areas 
of Sri Lanka. A cross-disciplinary team of RTI technical staff collaborated 
to evaluate how the current sample repository could be analyzed at RTI; the 
data were subsequently used to characterize further potential CKDu risk 
factors and provide additional insight into the necessary structure of a more 
comprehensive follow-up study on CKDu. 
Based on the research reviewed and regional geochemical analysis study, 
we explored recommendations for developing a more comprehensive and 
definitive way to identify CKDu risk factors in a subsequent study. We also 




The RTI team first conducted a comprehensive literature review on CKDu in 
Sri Lanka to identify data gaps. The review included evaluating both focused 
studies that hypothesized that a single risk factor may be related to CKDu 
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and a broader study that made an effort to approach the causes of the CKDu 
epidemic in Sri Lanka from a multifactorial standpoint.
The emerging CKDu crisis in Sri Lanka prompted a variety of investigations 
to determine the scope and causes of the disease. The broad research topics 
studied thus far include fertilizers with metal contaminants; pesticides, 
including organophosphates and glyphosate; mycotoxins, including ochratoxin 
A; hydrogeochemistry, including fluoride in water; and cookware and cooking 
practices. Our summary describes the findings of both highly focused studies 
and more broadly focused studies.
Focused Studies
In an effort to determine both the extent and potential risk factors of CKDu 
in Sri Lanka’s North Central Province, researchers have recently conducted 
several etiological studies.3 Cadmium is a known nephrotoxin and has 
caused environmental contamination resulting from the application of 
some inorganic, phosphate-based fertilizers.25,26 Studies have reported 
renal tubular dysfunction following environmental exposure to cadmium 
elsewhere in Asia.27,28 As rice and freshwater fish are important components 
of the Sri Lankan diet,29 several studies explored cadmium levels in these 
media obtained from endemic area irrigation and drinking waters.30-33 
Other investigations have explored potential CKDu linkages with exposure to 
acetylcholinesterase (AChE)-inhibiting organophosphate pesticides or metal-
chelating glyphosate broad-spectrum herbicides.34,35
The historic use of arsenic-containing pesticides has also prompted 
studies on the potential exposure to this element and the genesis of CKDu.36 
Other laboratory studies estimated the presence of nephrotoxic mycotoxins, 
including ochratoxin A, in food and CKDu patients within the endemic area 
or the deficiency of the glucose-6-phosphate dehydrogenase (G6PD) enzyme 
protecting against oxidative stress.8,37 Ayurvedic medicines have also been 
cited as a potential factor in the genesis and progression of CKDu because of 
their high prevalence in Sri Lanka.38
In addition to its potential exposure from agrochemical-based 
nephrotoxins, Sri Lanka’s CKDu-endemic area is within the country’s 
dry zone (see Figure 7.1), which is characterized by a unique, complex 
hydrogeochemistry. Alternating wet and dry cycles can affect soil redox 
potential and other physiochemical characteristics (e.g., organic matter, pH, 
conductivity, cation exchange capacity) that determine heavy metal mobility 
and bioavailability. Also within the endemic area are regions with moderate to 
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highly elevated fluoride content in their groundwater.39 This phenomenon has 
prompted some investigators to speculate that elevated levels of this analyte, in 
combination with other factors, including the leaching of aluminum from low-
grade cookware, can contribute to the genesis of CKDu.40,41
The tubulointerstitial progression of CKDu and its prevalence in 
the agricultural dry zone of Sri Lanka spurred many narrowly focused 
investigations seeking to identify population susceptibility or the presence 
of one or more environmental nephrotoxins, specifically agrochemical 
contaminants. However, because most studies focused on one potential CKDu 
risk factor, many studies involved small sample sizes, dated field collection or 
laboratory analytical methods, or incomplete media studied (e.g., biological, 
environmental, food). Study conclusions are therefore often difficult to 
replicate, resulting in more questions than answers.
Broader Study
The most comprehensive study undertaken on the CKDu issue in Sri Lanka 
was the product of a collaborative effort between the Ministry of Health 
(MoH) and WHO. This case-control study was conducted from 2009 through 
2012 and sought to determine the prevalence and risk factors of CKDu 
in the endemic area; it featured heavy metal, pesticide, and biochemical 
measurements of biological and environmental samples. The biological sample 
types included urine, blood serum, hair, and nails. The environmental sample 
types included water, food (e.g., rice, vegetables, and fish), fodder (e.g., pasture, 
weeds), tobacco, pesticides, and fertilizer. Although the investigators collected 
samples for each of these sample media, the number of samples varied by 
media type. As an example, biological samples included 733 CKDu cases, but 
between 57 and 495 individuals were chosen for urine, serum, hair, and nail 
samples; most individuals were tested only for three heavy metal constituents. 
The environmental samples also varied in collection size and analysis 
procedures. For example, 119 food samples were collected from endemic areas 
and 32 were collected from nonendemic areas, whereas 88 soil samples were 
collected from endemic areas and 41 samples from nonendemic areas.
This study reached two conclusions. First, chronic exposure to low levels 
of cadmium through the consumption of contaminated food and water is a 
risk factor in how CKDu develops. Second, selenium deficiency and genetic 
susceptibility may also be predisposing factors.42
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Although the MoH and WHO collaborative study represented an early 
multifaceted effort to identify the risk factors of CKDu in Sri Lanka, the 
findings have been controversial, and many questions remain unanswered.41 
Based on the critical analysis of the Sri Lankan MoH-WHO study, we 
recommended (in a previously published paper23) doing the following:
1.  Further evaluate the CKDu case definition and refine medical testing 
procedures, as needed.
2.  Geospatially link biological and environmental samples.
3.  Provide more comprehensive information on the overall study design 
and field protocols.
4.  Provide more comprehensive information on the laboratory protocols.
5.  Publish additional studies on CKDu in Sri Lanka and integrate the 
findings.
These critical analyses identified several potentially significant study 
design flaws.23 Some observers have claimed that the conclusions were 
“predetermined” in response to enormous political and economic pressure 
applied by the agrochemical industry.43
Data Gathering and Partnership
Before RTI’s involvement, field research design, brief participant interviews, 
and sample collection had been completed in 2012 and 2013 through a 
partnership between the Faculty of Medicine, University of Kelaniya (Sri 
Lanka); the Faculty of Medical Sciences, University of Sri Jayewardenepura 
(Sri Lanka); the University of Alabama at Birmingham’s Department of 
Epidemiology (USA); and the Sri Lanka Atomic Energy Authority. The Sri 
Lankan collaborators conducted field design and completed sample collection 
in 2012 and 2013. 
The Institutional Review Board of the University of Kelaniya approved 
informed consent and study protocols. The investigators collected a repository 
containing biological samples, including blood and hair, and supporting 
environmental media, including regional freshwater fish, locally harvested rice, 
drinking water, and soil samples, from CKDu cases and non-CKDu controls in 
endemic areas. The towns of Medawachchiya and Medirigiriya were the study 
sites within the North Central Province endemic area (Figure 7.2). 
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In response to the scope of the CKDu crisis and the lack of consensus 
concerning the MoH-WHO collaborative study findings, RTI and Sri Lankan 
collaborators formed a partnership in late 2013.24 RTI personnel subsequently 
traveled to Sri Lanka for a data-gathering trip with university partners; the 
main goals were to gather general insight on the current knowledge of CKDu 
in the population and to arrange for transport of the sample repository 
and associated data to RTI International in Research Triangle Park, North 
Carolina, USA, for subsequent laboratory analysis.
Figure 7.2  Sampling areas in two endemic dry zone regions of Sri Lanka
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The study collected biological samples from men ages 29 to 62 living in 
the North Central Province region. Environmental samples came from the 
environs of the study participants’ residences, and local rice farmers and 
fishermen in the general north Central Province region provided food samples. 
Some individuals were undergoing ongoing medical treatment for CKDu; 
the diagnosis was confirmed in living patients by small, echogenic kidneys, 
elevated serum creatinine levels, and the presence of proteinuria via dipstick 
urine test without hypertension, diabetes, or other renal disease at the time of 
diagnosis. Controls were individuals living within the study areas but who had 
no biochemical evidence of CKDu.
Laboratory and Data Analysis
Following sample transport, RTI completed the advanced, blinded laboratory 
analyses at its headquarters in Research Triangle Park, North Carolina, 
between November 2013 and March 2014. The RTI Institutional Review Board 
approved the protocol.
The sample repository included three media types: environmental (soil and 
water), biological (blood), and food (rice and fish). RTI scientists analyzed the 
samples for targeted analyte concentrations using an array of state-of-the-art 
instrumentation; we sought to determine the concentration of a suite of heavy 
metals and additional trace elements and ions linked with CKDu in literature 
reports and other elements of interest. Appropriate quality control samples 
were processed along with study samples to ensure a high level of data quality. 
Collection of scientifically defensible data is critical because many published 
reports on this topic have been challenged on the grounds of irreproducible 
data and inadequate protocols. Additionally, RTI laboratories have extensive 
experience with measurement equipment that is not available to CKDu 
researchers in Sri Lanka.
We used a sensitive, broad-panel metallomics and mineralomics approach 
to generate geochemical laboratory analytical data. These data allowed 
us to determine whether the regional mean and maximum levels of these 
constituents in the CKDu endemic area are of potential concern in comparison 
with risk screening levels or published mean and maximum values. These 
advanced laboratory analyses addressed some of the controversial nephrotoxin 
findings in the MoH-WHO collaborative effort. Specifically, the analyte suite 
included up to 18 metals and minerals, including cadmium, arsenic, selenium, 
and fluoride. We used advanced sample preparation (cleanroom facility and 
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high-purity reagents) and analysis instrumentation. These techniques included 
inductively coupled plasma mass spectrometry (ICP-MS), inductively coupled 
plasma optical emission spectrometry (ICP-OES), ion chromatography (IC), 
and combustion atomic absorption spectrometry (CAAS).
Staff analyzed several laboratory QC samples with a sample batch. Method 
blank data consistently indicated that analyte background contribution from 
the employed reagents and procedures was not significant.
Results
We conducted a regional geochemical analysis of the RTI laboratory analytical 
data by conducting basic statistics that identify the constituent concentration 
mean, minimum, and maximum values for the multimedia samples collected. 
We compared these values against other publicly available risk screening 
data (e.g., for soil and water) or published values (e.g., for blood). We also 
reviewed the data gaps in the current sample repository and recommended 
the completion of a comprehensive multimedia and georeferenced sample 
collection with associated survey information in a follow-up study. 
The objective of this limited geochemical laboratory analysis was to 
determine the concentration of metals and trace element nutrients in 
biological samples (human whole blood and hair), food samples (fish and 
rice), and environmental samples (drinking water and soil). We quantified 
the geochemical concentrations in biological and environmental media and 
subsequently used basic statistical measurements to compare media against 
applicable benchmark values, such as US soil screening levels. Laboratory 
analytical findings for the biological, food, and environmental study samples 
from Levine et al.24 include the following findings:
• Blood: Cadmium and lead blood concentrations exceeded mean US 
reference values from healthy nonsmokers for 68.7 percent and 89.2 
percent of the samples, respectively.
• Hair: Mercury levels in hair exceeded US mean reference values in 60.7 
percent of the samples.
• Rice: The maximum measured cadmium concentration in rice is below 
the Codex Alimentarius Commission reference level and maximum 
allowable concentration for Chinese rice.
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• Fish: Observed concentrations were similar to or lower than other recent 
literature reports.33,42 However, this sample size was limited and not 
directly linked to consumption habits.
• Soil: Arsenic, chromium, copper, iron, mercury, manganese, nickel, 
lead, and selenium concentrations exceeded mean background US soil 
concentrations. Within the limited number of soil samples, arsenic levels 
were determined to be above initial risk screening and mean background 
concentration reference levels.
• Drinking Water: Fluorine, iron, manganese, sodium, and lead exceeded 
applicable drinking water standards in some cases. Analyses revealed 
elevated fluorine levels, and many samples had “hard” or “very hard” 
water.
These biological data suggest that the population within the North Central 
Province is subject to chronic low-level exposure to cadmium, lead, and 
mercury. Analysts did not find that food samples exceeded reference values or 
standards. However, rice and freshwater fish are both important components 
of the Sri Lankan diet. Thus, given the relatively small number of samples 
collected from this limited study and the amount of these dietary food 
staples ingested, chronic exposure to cadmium could act as an environmental 
nephrotoxin. Accordingly, we recommend ongoing monitoring of these and 
other food staples in any subsequent laboratory analytical analysis designed to 
capture data that can be used to evaluate potential CKDu risk factors. 
Environmental samples exceeded reference values and risk screening 
standards in certain cases, including arsenic, chromium, copper, iron, mercury, 
manganese, nickel, lead, and selenium in soils, and fluorine, iron, manganese, 
sodium, and lead in water. Overall, data collected from study drinking water 
samples reflected the unique hydrogeochemistry of the region, including 
elevated levels of several elements (e.g., fluorine and iron) and the prevalence 
of hard or very hard water.
We presented our findings at the US Environmental Protection Agency’s 
National Institute of Environmental Health Sciences at Research Triangle 
Park. We also provided educational awareness, a critique of the MoH-WHO 
study, and a summary of our laboratory analytical results in three separate 
papers.10,23,24
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Discussion
Studies to date have focused on a variety of potential risk factors for CKDu 
in Sri Lanka and other CKDu hot spots. The goals of our limited regional 
geochemical analysis study were twofold: (1) to complete broad panel element 
analyses of biological (human whole blood and hair), food (rice and freshwater 
fish), and environmental (soil and drinking water) samples collected from the 
CKDu-endemic area in Sri Lanka’s North Central Province and (2) to use the 
data from this regional geochemical analysis to inform future multifactorial 
investigations regarding CKDu risk factors. 
Our team focused on publishing a study analyzing a limited set of 
multimedia biological and environmental samples. Our aim was to identify 
whether metals or fluoride may be present above average levels based on 
standard health benchmarks and population averages. Given the relatively 
small sample size of this study, we could not definitively identify any single 
hydrogeochemical condition, environmental nephrotoxin, biochemical 
parameter, or other regional geochemical risk factor that could be linked to 
CKDu. 
This preliminary screening identified that specific constituents may be 
present above levels of concern, but it did not compare results against specific 
kidney toxicity values or cumulative risk related to a multifactorial disease 
process. The data from this limited investigation are intended to be used in 
the subsequent study design of a comprehensive and multifactorial etiological 
study of CKDu risk factors that includes sample collection, individual 
surveys, and laboratory analyses to comprehensively evaluate the potential 
environmental, behavioral, genetic, and lifestyle risk factors associated with 
CKDu. 
The complex nature of the unfolding CKDu health crisis in Sri Lanka and 
the significant remaining data gaps necessitate a multidisciplinary large-scale 
study. The etiology of CKDu is likely related to multiple risk factors including 
genetic predisposition, nutritional, behavioral and lifestyle factors, and 
exposure to one or more environmental nephrotoxins.
Conceptual Model
In Figure 7.3, we present a potential conceptual study model based on research 
conducted to date. This framework is organized by source; release, fate, and 
transport mechanisms; exposure media; exposure route; and human receptors.
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This conceptual study model presents an example of the sources, media, 
and exposure pathways to consider. Nevertheless, it may change based on 
additional evaluation or new research findings. Researchers could evaluate 
potential mechanisms of action for CKDu genesis and progression based 
on the various risk-factor hypotheses. For example, metal nephrotoxins are 
often cited as potential concerns associated with agrochemical use, whereas 
generalized kidney stress may be related to lifestyle or behavioral factors such 
as dehydration and undernutrition.
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A critical component of this approach is collecting data to obtain a better 
understanding of occupational, nutritional, hydration, and behavioral habits 
for agricultural workers and residents. In future studies, we also recommend 
including an in-depth survey questionnaire that considers demographic, 
lifestyle, and behavioral factors as potential additional exposure routes and 
media (e.g., tobacco use, vegetable consumption, and potential occupational 
exposures). Doing so will create a more robust informational dataset linked to 
laboratory analyses and let investigators consider cumulative exposures more 
fully.
Georeferenced Study Location and Receptor Population
To maximize the impact of robust data and appropriate interpretation, 
we propose two key actions: (1) any subsequent investigation should be 
conducted at “hot spot” locations within the endemic area in Sri Lanka, 
and (2) control groups should ideally consist of both asymptomatic villages 
within the endemic area and villages from nonendemic areas. Additionally, 
studies should link all multimedia sample data directly to field questionnaire 
information by sample identification and georeferenced location. As noted in 
Redmon et al., an approach that includes multimedia sampling and analysis 
along with georeferencing allows for more rigorous comparative data analysis, 
multivariate linear regression modeling, and human health risk assessment 
that will decrease the overall uncertainty associated with the corresponding 
results.23 
Further refining the CKDu case definition, developing an early diagnostic 
technique, and determining which geographic areas and hydrogeochemical 
parameters to include will also be critical in further differentiating endemic 
and nonendemic areas in the region. Lastly, efforts should be made to identify 
causal commonalities between CKDu in Sri Lanka and CKDu hot spots 
elsewhere in the world.
Quality Control
Another critical facet of future CKDu studies is early implementation of 
rigorous quality control procedures for both field sample and questionnaire 
data collection and laboratory analyses. Researchers should use both 
standardized protocols and advanced equipment and analytical methods to 
collect samples in the field and analyze them in the laboratory. 
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In studies to date, using inconsistent quality control procedures has 
complicated efforts to replicate study findings and has contributed to an 
atmosphere of distrust. Employing advanced sample preparation and analysis 
instrumentation with adequate sensitivity and resolution power to determine 
analytes of interest is critical, as are open and transparent quality-control 
procedures with a priori defined acceptance criteria. These protocols will 
bolster confidence in study findings within the scientific community and for 
the public at large.
Using a secondary, independent testing laboratory to prepare and analyze 
duplicate samples to compare analyte results is also important. Testing 
may focus on heavy metals, pesticide residues, genetic susceptibility, and 
biomarkers in biological and environmental samples. Implementing this step 
will provide further credibility to the results.
Data Evaluation
Laboratory analytical results and survey information should be evaluated 
using appropriate statistical analyses, which can include multivariate linear 
regression modeling if the sample size is sufficient. Additionally, a multimedia 
human health risk analysis could be conducted using concentration data 
obtained through field study collection and subsequent laboratory analysis and 
survey information about demographics, behaviors, and lifestyle factors. This 
knowledge base would enable investigators to model average and high health 
risk estimates associated with exposure to environmental nephrotoxins.
Similar studies could be implemented in other CKDu-affected countries to 
identify cross-country linkages. Ideally, a multicountry study could implement 
the same field collection, survey collection, and laboratory analytical 
techniques in CKDu-affected areas in two or more countries to identify and 
compare risk factors that contribute to CKDu incidence by country (Table 7.1).
Table 7.1  Post–field collection data evaluation and synthesis
• Conduct state-of-the-science laboratory analyses.
• Perform statistical analyses to identify linkages and conduct multimedia human health 
risk analysis.
• Perform similar CKDu studies in other affected countries.
• Based on results, provide educational awareness and occupational health and safety 
training.
Source: Adapted from Elledge et al. (2014).10
120  Chapter 7
Educational Awareness and Training 
Expanded CKDu education access and coverage are desperately needed to 
address fears and aid in early detection. Current programs designed to reach 
high-risk and endemic communities are now under-resourced. Far too many 
patients are unable to access care and treatment consistently. Building the 
capacity of both the public health system and supporting testing laboratories in 
terms of equipment and professional staff training will be crucial components 
in the ongoing struggle against CKDu.
Providing educational awareness and occupational health and safety training 
to residents and public health providers will be critical within the endemic area 
and across Sri Lanka once researchers have unequivocally identified CKDu 
risk factors. Educators can base informational materials and educational or 
occupational training programs in Sri Lanka on the findings of a comprehensive 
field study to pinpoint the risk factors associated with CKDu. 
Identifying risk factors, encouraging better processes of diagnosis and 
treatment, and fostering improvement in health outcomes in endemic areas will 
require a robust decision-support approach, as well as working across health, 
agriculture, and environmental agencies. Effective educational awareness and 
occupational health and safety training about mitigating the risk associated 
with CKDu can also be extended to health workers in other countries with 
increasing CKDu prevalence once risk factors are more clearly identified.
Global Implications
Identifying commonalities between the CKDu epidemic in Sri Lanka and 
similar CKDu health crises across the world is important. Table 7.2 outlines 
key next steps in a global effort to deal with CKDu. Global health research 
Table 7.2  Important next steps for research and program development globally
• Share information as a public service and for research purposes.
• Strengthen disease registries and surveillance reporting systems for cases of CKDu.
• Develop capacity in national environmental toxicology and epidemiological networks, 
including the expansion and harmonization of laboratory equipment, protocols, and 
training to ensure data quality.
• Prepare an economic evaluation of CKDu to model the costs and societal impact in Sri 
Lanka and elsewhere to support CKDu advocacy.
• Evaluate and recognize the societal and economic impacts on communities and the 
nation as a whole.
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collaborations by professional and medical staff that would facilitate data 
exchange and provide training in countries affected by CKDu would benefit 
patients and public health systems in Sri Lanka, India, North Africa, Central 
America, and the Balkan Peninsula. Given the complexity of the CKDu issue, 
international multidisciplinary collaborations will be necessary to facilitate 
research and help to implement policy actions and community outreach 
designed to mitigate CKDu risks. To be successful, these collaborations must 
consider political sensitivities and complexities within the study county and 
seek to identify one or more in-country champions.
Conclusions 
The present burden of CKDu on the economy, the public health system, and 
families within affected communities is tremendous. The complexity and 
multifaceted nature of the emerging CKDu health crisis in Sri Lanka requires 
an interdisciplinary approach to identify the risk factors associated with CKDu 
and subsequently to achieve tangible, lasting improvement in health outcomes.
Key Findings and Lessons Learned
• Based on our study results and a review of current literature, we postulate that 
exposure to one or more environmental factors, coupled with behavioral or lifestyle 
conditions and a genetic predisposition of susceptible populations, may ultimately 
be responsible for CKDu genesis and progression. 
• Given the relatively small sample size of this study, we could not definitively identify 
any single hydrogeochemical condition, environmental nephrotoxin, biochemical 
parameter, or other regional geochemical risk factor that could be linked to CKDu. 
• This preliminary screening identified that specific constituents may be present 
above levels of concern, but it did not compare results against specific kidney 
toxicity values or cumulative risk related to a multifactorial disease process. 
• Our limited regional geochemical analysis was conducted to inform study design for 
a potential subsequent multifactorial investigation that will allow for more intensive 
statistical measurements, risk analysis, and modeling to improve the likelihood of 
identifying multiple CKDu risk factors. 
• The complex, multifaceted nature of the unfolding CKDu health crisis in Sri Lanka 
and the significant remaining data gaps necessitate a multifaceted, large-scale 
comprehensive study.
• RTI is well positioned as a multidisciplinary nonprofit research institute to 
collaborate with in-country investigators, clinicians, and policy makers to conduct 
a follow-up comprehensive study to decipher the risk factors associated with 
CKDu, and then subsequently provide educational and international development 
support.
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RTI International Grand Challenge:  
Improving Outcomes of Noncommunicable 
Diseases—What Did We Learn?
Kenneth A. LaBresh, Michael T. Halpern, and Kathleen N. Lohr
Overview
The studies funded by this RTI International Grand Challenge program 
explored a range of interventions across diverse noncommunicable diseases 
(NCDs) and NCD risk factors in multiple countries in Asia (specifically, 
China, India, Indonesia, and Sri Lanka). Although the pilot studies described 
in Chapters 1 through 7 were conducted on a small scale, they did collect 
information that will be key for future efforts to improve patient outcomes 
from NCDs in low- and middle-income countries (LMICs). Such information 
includes identifying best practices for addressing cardiovascular disease, 
stroke, or diabetes, and as a result of collaboration between RTI investigators 
and local partners, determining approaches for future work. In a couple of 
cases, the information has pointed the way to target research efforts more 
narrowly or to build on software programs and modeling to enhance clinical 
and policy decision making in the countries in question.
In this chaper, we review briefly the pilot projects, recognizing their 
limitations of time (on average, 18 months in all) and resources. Of the seven 
studies, three were conducted in India, two in Indonesia, and one each in 
China and Sri Lanka. The NCDs of interest were stroke, cancer (cervical; oral), 
diabetes, chronic kidney disease of unknown etiology (CKDu), and obesity 
and low birth weight. In all cases, we focus on the outcomes of these projects 
and the conclusions and recommendations that the investigators—from both 
RTI and local partners—drew from their work.
Many of these suggestions fall into the category of lessons learned. Some are 
country-specific and some are more generally applicable to LMICs in which 
these disorders are emerging or posing significant challenges to the health 
of patient populations and to public health more generally. A few projects 
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relied on advanced information technologies, the internet, or sophisticated 
modeling techniques. All addressed issues of critical concern to our in-country 
collaborators; maximized the advantage of their insights on potentially 
effective interventions; explored both facilitators for and barriers to successful 
implementation of prevention, screening, counseling, and treatment initiatives; 
and thought creatively about next steps.
Review of Project-Specific Accomplishments and Recommendations
In India, projects related to screening for and treatment of patients with 
oral cancer (Chapter 1) and cervical cancer (Chapter 2) enhanced our 
understanding of the problems and led to specific recommendations for 
improving public health and health care to enhance detection and facilitate 
early treatment. Effective screening and treatment of oral cancer in regional 
cancer centers are hampered by limited staffing at the centers, increasing 
use of tobacco products among these populations, and presentation for 
treatment at later stages of the disease. Important steps to address oral cancer 
include initiating health policies to regulate and make tobacco products more 
expensive, educating local healers to increase referrals to cancer centers earlier 
in the disease, and enhancing systems of care to maximize the effectiveness 
of existing medical staff. Increased staff resources may also help to improve 
patient outcomes when coupled with improvement in patient flow. 
Also in India, increased efforts at prevention and early diagnosis—such as 
human papillomavirus (HPV) vaccination for girls and screening and follow-
up of women—can enhance cervical cancer detection and treatment. Better 
evaluation efforts to enhance efficiency and effectiveness in the health care 
setting have the potential to enhance these programs and activities further.
One pilot project developed and applied a simulated population model to 
better understand the rapidly increasing prevalence of overweight and obese 
children and adults in Indonesia and to examine the links between low birth 
weight in infants, the phenomenon of stunting among children, and obesity 
in later years (Chapter 3). The project also sought to project future rates of 
these conditions and estimate the effect on rates of NCDs. The study featured 
an innovative survey to provide timely data for some of the modeling efforts. 
Understanding the trajectory of obesity and related diseases will be useful to 
policy makers in developing public health and health care interventions based 
on the health and economic costs of those diseases.
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Three other pilot projects in three different LMICs entailed brief to 
complex interventions (one for diabetes, two for stroke). All sought to change 
behaviors of clinicians or patients (or both) to facilitate use of evidence-
based information, prevention strategies, and treatment options. The specific 
activities differed markedly across these efforts, chiefly in response to the real 
or perceived needs and concerns of local partners and interest in evaluating 
innovative interventions.
In a clinical setting in India (Chapter 4), internet-generated patient 
education handouts about diabetes medications were generated in the local 
language (Malayalam). These were given to patients, as part of the medical 
visit, to inform them about diabetes management, enhance patient motivation, 
and improve diabetes control. Although patients and staff found the handouts 
useful (and wished they were also available for other conditions), barriers 
such as unpredictable lapses in internet access complicated the overall 
implementation.
In China, interfaces between electronic medical systems for stroke care 
were integrated to automate, at least partially, the collection of data to measure 
important care processes and outcomes of both treating acute stroke patients 
and preventing recurrence (Chapter 5). One element of improving stroke 
care quality is the measurement of key clinical processes, which is usually 
labor-intensive. Stroke programs in the United States, for example, employ 
full-time stroke coordinators to facilitate measurement and feedback for key 
care processes. Reducing the administrative burden of collecting these data, 
particularly in LMICs, will make measurement and feedback more feasible. 
Such advances, based on available information technology, will allow hospitals 
to devote more time to improving processes that are critical components of 
caring for stroke patients.
A brief intervention in community health centers in Indonesia aimed to 
enhance patient knowledge of stroke risk factors and provide motivation for 
change in patient behavior and in the delivery of health care in this small 
pilot program (Chapter 6). Future efforts to enhance understanding of stroke 
risk factors will need to include specific training to enhance (yet simplify) 
workflow, such as incorporating an existing behavioral psychologist to support 
patients (and families) in making lifestyle changes necessary to reduce the 
future occurrence of stroke.
Finally, CKDu in Sri Lanka (and other LMICs) (Chapter 7) is an important 
but not well-understood cause of renal failure. Understanding the problem 
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better will entail strengthening disease registries and surveillance reporting 
systems for cases of CKDu and developing capacity in national environmental 
toxicology and epidemiological networks. This will call for expanding the 
harmonization of laboratory equipment, protocols, and training to ensure data 
quality. It also calls for creating an economic evaluation of CKDu to model the 
costs and societal impact on Sri Lanka as a whole and specific communities in 
particular. Such efforts, and the resulting information, can provide a basis for 
advocacy to prevent this condition and improve treatment for patients who are 
already affected by it.
Products and Next Steps for These RTI Grand Challenge  
Pilot Projects
These RTI Grand Challenge pilot projects were conducted largely in 2013 
and 2014. RTI also convened a one-day summary conference in 2015 where 
the investigators and outside experts presented and extensively discussed 
these projects and their outcomes. This symposium prompted us to prepare 
this book. Many investigators have published meeting abstracts or journal 
manuscripts,1-5 and others are exploring opportunities for grant support 
through the US National Institutes of Health. Some of the project leads have 
given presentations or prepared reports for government officials in the host 
countries.
Equally important, this RTI Grand Challenge gave RTI researchers an 
opportunity to experience conducting research in LMICs. More important, 
they were able to begin developing collaborations with researchers and 
clinicians in these countries. These collaborative networks will likely be the 
basis of multiple future studies, including some that go well beyond activities 
planned during the RTI Grand Challenge.
Looking Ahead: Recommendations for Future Research and  
Related Actions
As a result of the experience gained from this group of seven pilot projects, 
we and the investigators offer the following recommendations to enhance our 
collaborative work to reduce the burden of NCDs in LMICs. These reflect the 
key findings or lessons learned identified specifically in Chapters 1 through 7.
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Establish Research Infrastructures That Facilitate Studies in LMICs
Many US-based research organizations and institutions may not be familiar 
with the procedures and requirements for conducting studies in LMICs. 
Developing a project management and administrative support system 
dedicated to LMIC research will likely facilitate such studies and encourage 
researchers to pursue work in this area. Furthermore, creating and fostering 
“communities of interest,” bringing together those interested in LMIC-based 
research with others who have experience in this area, will also help to identify 
and prospectively address governmental, health care system, and cultural 
barriers that often impede studies of NCDs in these countries.
Involve Professionals from LMICs
A foundational principle of community-based participatory research is the 
inclusion of individuals from the communities being studied. Community-
based participatory research emphasizes the community’s role in identifying 
research priorities, developing study plans, reviewing study findings, and 
disseminating results. These principles clearly extend to collaborative research 
of the sort documented in this book.
Thus, for research to improve NCD outcomes in LMICs, a critical step will 
entail involving research and health care professionals in those countries in all 
aspects of such efforts. This explicitly includes planning studies, implementing 
the proposed programs, tracking performance, documenting outcomes, and 
disseminating results. Focusing projects on areas where research collaborators 
are located and where research infrastructures already exist will also increase 
the efficiency of work in LMICs.
Provide Flexible Research Opportunities
Many preliminary or proof-of-concept studies to develop or test interventions 
can be performed quickly with limited budgets. If they prove successful, larger 
pilot studies can be undertaken. Even if not fully successful, replication or 
scaled-up efforts, drawing on the specific lessons learned from the pilot, may 
be possible.
For preliminary studies, developing a cash reserve to provide small amounts 
of funding quickly would be useful. Flexible approaches to financial support 
for various types of studies, but particularly to explore potentially promising 
interventions and to reach out to changing health care environments in 
LMICs, offer attractive options for expanding this type of research across these 
(or other) NCDs in these (or other) LMICs.
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Develop Improved Data Collection Systems in LMICs
Collecting epidemiologic, medical, and patient-reported data will be vital for 
developing interventions with the potential to improve NCD outcomes in 
LMICs; similarly, such capabilities are a prerequisite for assessing the impact of 
such interventions. This imperative clearly includes data collection in different 
regions of or among diverse populations in a given country.
Few LMICs have comprehensive data collection systems today. Most 
have systems that acquire only limited information in specific regions of the 
country. Fortunately, developing data collection and analysis systems in LMICs 
is relatively low in cost. In some cases, these efforts can be included as part of 
broader studies.
In addition to assisting with research, intervention development, and 
program evaluation, systems to collect vital statistics and other epidemiologic, 
health care, and patient outcomes information are needed. They can be 
expected to strengthen existing health care systems, to expand and increase 
the impact of prevention activities, and, at least indirectly, to improve patient 
outcomes.
Consider Mutual Benefits from Studies in LMICs
Approaches or strategies developed in LMICs may be of benefit in certain 
US health care settings. This can be classified as “reverse innovation”; that 
is, effective and low-cost programs developed in LMICs may also provide 
effective and low-cost health care benefits advantageous for specific US 
population groups.
Research costs are often substantially lower in LMICs than in the United 
States (or other highly developed countries). For that reason, performing work 
in LMICs that is mutually beneficial may be financially advantageous across 
the board. In developing future studies, researchers need to think strategically 
about approaches that are feasible in both LMICs and the United States. 
Such interventions and study designs might employ mobile technologies, 
telemedicine, or community health workers. In particular, disruptive 
innovations that can potentially have substantial benefits in LMICs may also 
be game-changers in higher-income countries.
Include a Broad Range of Outcomes
Many health care studies conducted in LMICs have focused on changes in 
mortality rates. Although this is appropriate for studies of infectious diseases 
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and other potentially fatal acute conditions, it is not the only outcome of 
interest for studies of NCDs. Studies of interventions to improve NCD 
outcomes need to include measures such as morbidity and quality of life, with 
the latter assessed through patient-reported outcomes. Also of interest are 
measures of the use of services and costs of care. Finally, apart from the focus 
on patients and their outcomes are concerns with impacts on clinicians and 
other staff in hospitals, clinics, and other settings, as well as quality of life. 
These also need to be measured when expanded use of technologies and major 
changes to settings, workflow, or established procedures are set in motion.
Plan for Translation and Sustainability of Study Findings
In planning for studies of NCDs in LMICs, considering the translation of 
research findings is critical. Investigators, funders, and policy makers need to 
think in advance about how study results can be used to produce sustainable 
actions. These considerations include broader implementation of successful 
interventions (scaling them up) and support for policies that facilitate and 
enhance such interventions. Part of conducting ethical and responsible 
research in LMICs is planning for a continued benefit of a study to the relevant 
populations after the research is completed.
Concluding Thoughts
The epidemic of NCDs represents a challenge to the health and well-being of 
the world’s population. The disproportionate impact in LMICs is particularly 
challenging because they have many fewer resources to quell the epidemic. 
Clearly, acute treatment is not a viable sole option in this fight. As some 
have said, you cannot treat yourself out of the epidemic of, for instance, 
cardiovascular disease.
Numerous important initiatives can be considered. For example, population 
health approaches can reduce the development of risk factors (or exposures 
to environmental risk factors). Public policy initiatives can reduce tobacco 
use, improve the availability of nutritious food, increase the number of safe 
areas for physical activity, and reduce time spent in front of electronic screens. 
Modeling studies can provide detailed information about options that public 
health officials can use to make important decisions about the focus of 
proposed programs in the context of estimated costs and outcomes over the 
long term. In the health care system, a shift from on-demand acute care to 
preventive care provided by nonphysician professionals skilled in behavior 
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change, together with use of contemporary information technologies for 
patient and family education, all offer opportunities for both primary and 
secondary prevention efforts.
As the RTI Grand Challenge projects demonstrate, creative use of expertise 
and local partnerships can provide an approach that is more cost-effective 
and culturally sensitive to the populations to be served and the systems to be 
enhanced. One very important lesson is that partnerships with local experts 
in LMICs—who have a clear understanding of cultural, economic, and 
systems factors—are an invaluable ingredient in addressing the expanding and 
devastating problem of NCDs. These relationships will be critical in future 
work to reduce the impact of NCDs on the world’s populations. In pursuing 
these goals, RTI has been honored and gratified to be able to pursue its mission 
of improving the human condition. We look forward to contributing to this 
important enterprise in coming years.
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This book succinctly summarizes the results of a Grand Challenge project from 
RTI International. If you are looking for a work long on hand-wringing about the 
challenges of noncommunicable diseases (NCDs) in low- and middle-income 
countries (LMICs), this is not for you. 
But if you are searching for a series of creative, inspiring, and yet practical 
approaches that target significant problems for humanity, transcend traditional 
segmented disciplines, are challenging to implement, but are clearly achievable . . . 
this book is just what the doctor ordered!
—Gray Ellrodt, MD, Chief of Medicine and Director of the Internal Medicine Training Program, 
Berkshire Medical Center
The alarm has been sounded. Developing countries are facing major public health 
challenges with the rapid rise of noncommunicable diseases. Although hidden 
behind the news headlines and a clearly important focus on the suffering caused 
by the Ebola and Zika viruses, the alarming and rapid increase in the incidence of 
chronic diseases in low- and middle-income countries (LMICs) must be addressed by 
the global health community. This clarion call was highlighted by the United Nations, 
particularly in its statement that members must ensure healthy lives and promote 
well-being and, specifically, “by 2030 reduce by one third premature mortality from 
non-communicable diseases through prevention and treatment.” 
RTI International has responded to this evolving crisis by applying its considerable 
expertise across a range of interventions in several LMICs. The featured pilot 
projects, launched under a “Grand Challenge” framework, are grounded in the real 
world of primary health care. They were implemented in collaboration with frontline 
health care professionals who are grappling with this surge in largely preventable 
diseases. Effective partnerships will be crucial for meeting the global challenge, 
and RTI has offered a bold but pragmatic roadmap for future engagement with local 
practitioners, aimed at addressing this new global health threat and saving lives.
—Aaron Williams, Director of the US Peace Corps (2009–2012), 
Executive Vice President, RTI International
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